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Abstract 
Determining the roles of dendritic cells and ICAM-1 in the transpresentation of IL-15 to 
CD8 T cells 
The maintenance and generation of memory CD8 T cells is dependent on the cytokine IL-15.  
IL-15 is delivered by a novel mechanism termed transpresentation: IL-15 is presented by a cell 
expressing IL-15R to the CD8 T cell which responds via IL-2R/c.  The identity of what cells 
transpresent IL-15 to support the survival and homeostatic proliferation of memory CD8 T cells 
is unknown.  Using a transgenic mouse model that limits IL-15 transpresentation to DCs, I 
have demonstrated that DCs transpresent IL-15 to CD8 T cells.  DCs transpresent IL-15 to 
CD8 T cells during the contraction of an immune response and also drive homeostatic 
proliferation of memory CD8 T cells.  Additionally, I identified a role for ICAM-1 in promoting 
homeostatic proliferation.  Wt memory CD8 T cells displayed impaired homeostatic 
proliferation in ICAM-1-/- hosts but not in models of acute IL-15-driven proliferation.  In this 
way, the role of ICAM-1 in IL-15 transpresentation resembles the role for ICAM-1 in antigen-
presentation: where antigen or IL-15 is limited, adhesion molecules are important for 
generating maximal responses.  In vitro cultures between CD8 T cells and bone marrow-
differentiated DCs (BMDC) activated with a TLR agonist established a model of proliferation 
and signaling in CD8 T cells that was dependent on IL-15 transpresentation and required 
ICAM-1 expression by BMDCs.  Regarding the expression of IL-15, I demonstrated that in 
normal mice it is undetectable without stimulation but is elevated in lymphopenic mice, 
suggesting a role for T cells in regulating IL-15 expression.  Overall, these studies have 
identified many novel aspects of the interaction between DCs and CD8 T cells that were 
previously unknown.  The study of adhesion molecules in IL-15 transpresentation describes a 
novel role for these well-known adhesion molecules and it will be interesting for future studies 
to further characterize this relationship for other IL-15-dependent cell types.   
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Introduction 
 
The immune system exists to protect host organisms against infectious organisms by 
eliminating these pathogens once they’ve been detected: a further goal is the establishment of 
a bulwark against the reoccurrence of a given pathogen.  The immune system uses a multi-
pronged approach to control and eliminate infectious organisms and CD8 T cells are an 
important feature in this response as they are responsible for recognizing and killing cells that 
have become infected.  By killing infected cells, CD8 T cells remove cellular reservoirs that 
can produce and disseminate more virus.  What’s more, after the immune response has 
resolved, these pathogen-specific CD8 T cells – now called memory CD8 T cells – are part of 
said bulwark as they can now more swiftly curtail the infection by virtue of having experienced 
the given pathogen before.  This abbreviated infection is important in that the overall immune 
system engagement is lessened, resulting in less immune pathology, and the pathogen itself 
is not allowed to disrupt the host as it otherwise would.  Maintaining this pool of pathogen-
experienced memory CD8 T cells is therefore an important component to the future protection 
of an organism.  As various aspects of memory CD8 T cell biology are dependent on the 
cytokine IL-15, uncovering the mechanisms behind the unique delivery of this cytokine will be 
useful in developing methodologies to augment or enhance the CD8 T cell memory pool and 
could be translated into better host protection.   
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Chapter 1: Background 
1.1   CD8 T cell development and immune responses 
T cell development begins with T cell progenitors leaving the BM and migrating to the thymus.  
Upon arriving in the thymus, CD4 and CD8 double-negative (DN) T cell precursors undergo a 
series of developmental steps that are characterized by changes in CD44 and CD25 
expression: CD44+ CD25- (DN1), CD44+ CD25+ (DN2), CD44- CD25+ (DN3), and CD44- 
CD25- (DN4) (1).  Accompanying these fluctuations in CD44 and CD25 expression is the 
rearrangement of T cell receptor (TCR) genes that ultimately yields the β-chain of the TCR(1).  
The genes encoding the TCR β-chain are sequentially rearranged, first by combining D-J 
genes, then V genes to the combined DJ genes.  
 
 The successful creation of the TCR β-chain enables a cell to exit the DN4 stage where the β-
chain is then paired with a surrogate α-chain, pre-T-cell receptor α-chain (pTα), and begins to 
express CD3 (2).  Developing T cells that have a functional TCR β-chain will gain expression 
of CD4 and CD8 and turn off β-chain gene rearrangement as well as undergo proliferation (2).  
Subsequent to proliferating, each developing T cell has the opportunity to arrange an α-chain 
to pair with the pre-existing β-chain that will replace pTα.  α-chain rearrangements occur 
between V and J genes and these putative α-chains pair with the β-chain to form an αβ-TCR 
(2).  The process of randomly rearranging V, D, and J genes results in a combinatorial 
diversity of antigens that T cells can recognize, which is crucial to protecting the host against a 
wide variety of pathogens.  At this stage in T cell development, developing T cells are found in 
the cortical region of the thymus where they come in contact with cortical epithelial cells.   
Cortical epithelial cells present antigens via major histocompatibility complex (MHC) class I 
and II for positive selection (3) of developing T cells with a functional TCR, i.e. capable of 
recognizing antigen.  The CD4 and CD8 co-receptors at this stage are important for allowing 
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cells bearing αβ-TCRs the ability to interact with MHC class I or II, and their preference for 
either will be in part determined by the nature of the antigens presented.  MHC class I and II 
molecules possess different peptide binding abilities and this limits the variety of peptide 
antigens that either molecule can present.  Positive selection occurs to allow a diverse set of 
TCRs to develop; however, it is also crucial to eliminate T cells that bear TCRs specific for 
self-antigens.  T cells that recognize self-antigens presented by dendritic cells (DCs) and 
macrophages in the medulla of the thymus (4) will be deleted so that they do not mature 
further.  This process of positive and negative selection ensures a pool of CD4+ and CD8+ 
single-positive T cells that recognize diverse antigens but will not react against host peptides. 
 
CD8 T cells that survive thymic selection reside primarily in secondary lymphoid organs such 
as the lymph node where they continually interact with migrating DCs to scan for the antigen 
for which their T-cell receptor is specific.  These naïve CD8 T cells are quiescent and require 
IL-7 and require interactions with MHC class I for survival (5,6).  Immature DCs constantly 
sample antigen through phagocytosis and pinocytosis in peripheral tissues and migrate 
through secondary lymphoid tissues where they display the sampled antigens for the perusal 
of naïve CD8 T cells.  The naïve T cells themselves are motile and will continue migrating 
through the lymphatic system, sampling the antigens that DCs in secondary lymphoid organs 
are presenting.  In homeostatic conditions, these T cell:DC interactions will not yield an 
immune response.  In an infection, peripheral DCs can detect pathogens through surface 
receptors called Toll-like receptors (TLRs) that recognize conserved bacterial or viral 
components, i.e. bacterial cell-wall components or double-stranded DNA in endosomes, 
resulting in their activation.  TLRs are a tool the immune system has evolved to allow the 
detection of a wide variety of pathogenic species by simply recognizing conserved elements 
that different pathogens share in common.  The result of this TLR recognition and signaling is 
the expression of pro-inflammatory cytokines that can recruit other cells to the site of infection, 
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as well as inducing the expression of costimulatory molecules.  Activated DCs down-regulate 
their phagocytic functions and increase antigen processing as they migrate to the draining 
lymph node. 
 
In the context of an infection where DCs have been activated, the nature of T cell:DC 
interactions in secondary lymphoid organs changes.  Upon recognition of their cognate 
antigen, CD8 T cells form lasting contacts (up to ~48 hours) (7) with DCs where the T cell 
receives both TCR signals (signal 1) as well as CD28 costimulation (signal 2) via CD80/CD86 
on the DCs (8,9).  The prolonged interaction between CD8 T cells and DCs is important in 
efficiently activating the T cell as T cells that receive TCR stimulation without sufficient 
costimulation become anergic and are not functional (8,9).  This is one way the immune 
system ensures T cells do not become active inappropriately – T cells seeing their specific 
antigen in the absence of “danger” signals (i.e. DCs not having responded via TLR) are 
essentially shut down.  The level of inflammatory cytokines present at the time of the T cell 
receiving signal 1 and signal 2 have also been implicated in impacting the outcome of CD8 T 
cell differentiation, which will be discussed more in detail later.   
 
TCR and CD28 signals serve to induce massive IL-2 production by activated CD8 T cells (9), 
which helps sustain the initial TCR-mediated proliferation that CD8 T cells undergo upon 
activation (10).  Several notable phenotypic changes accompany activation: the up-regulation 
of IL-2Rα (CD25) and the down-regulation of both IL-7Rα (CD127) and CD62L (11).  Up-
regulation of IL-2Rα increases the affinity with which CD8 T cells can bind IL-2 by pairing with 
IL-2Rβ and the common gamma chain (γc) (12).  Down-regulation of IL-7Rα and CD62L 
disables the ability of the T cells to respond to IL-7 and enables T cells to leave lymphoid 
tissues and migrate to peripheral locations, respectively.  Activated CD8 T cells then leave the 
secondary lymphoid organ and home to sites of infection where they begin killing cells bearing 
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their cognate antigen via the cytolytic granules perforin and granzyme B.  Additionally, 
activated CD8 T cells express TNF-α and IFN-γ, which are involved in inducing apoptosis and 
inflammation and increasing antigen presentation, respectively.  Antigen-specific naïve CD8 T 
cells exist in very small numbers: typically, for a given antigen, there exists between 50 and 
500 naïve CD8 T cells that can recognize that antigen (13).  In order to effectively combat the 
infection, upon activation these antigen-specific CD8 T cells undergo massive proliferation, 
which typically peaks one week after infection.  At the peak of the expansion phase, the 
population of antigen-specific CD8 T cells can comprise 20-40% of the total CD8 T cell pool, 
though this is not true for all CD8 T cell immune responses.   
 
During the expansion phase, a subset of CD8 T cells will re-express IL-7Rα while others begin 
to express KLRG-1, a marker of cellular senescence (14)  The IL-7Rα+KLRG-1- subset of CD8 
T cells are known as memory-precursor effect cells (MPEC), and their polar counterparts, 
those lacking IL-7Rα but expressing KLRG-1, are known as short-lived effector cells (SLEC) 
(15).  Following the zenith of expansion, the antigen-specific CD8 T cell population undergoes 
a contraction period during which the vast majority of these cells will die via apoptosis.  TGF-β 
production during the expansion phase of the immune response lowers Bcl-2 levels in 
activated CD8 T cells, contributing to their death in the contraction (16).  Addition of 
exogenous IL-2 or IL-15 at this time can counteract the contraction (17) by providing survival 
signals.  By virtue of IL-7Rα expression, MPECs are able to respond to both IL-7 and IL-15 
during the contraction, whereas SLECs are only responsive to IL-15.  This contributes to their 
differential survival during the contraction phase and their subsequent differentiation into 
memory.  Both MPECs and SLECs will both seed the memory pool but the SLEC population 
declines over time whereas MPECs persist and can self-renew.  Approximately one month 
after infection and directly following the contraction phase, surviving antigen-specific CD8 T 
cells are now considered memory CD8 T cells.  Importantly, the number of cells that survive 
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the contraction – i.e. the pool of memory CD8 T cells – is much higher than the number of 
initial naïve antigen-specific precursors.  This is one of the factors that contributes to the rapid 
response of memory CD8 T cells in the case of a secondary infection. 
 
Additional heterogeneity exists in memory CD8 T cells as defined by CD62L expression.  As 
mentioned previously, activated CD8 T cells lose CD62L expression but a subpopulation of 
CD8 T cells will regain CD62L once they have entered the memory phase.  CD62L+ memory 
CD8 T cells, known as central memory (Tcm), ostensibly differ from their CD62L- counterparts 
(effector memory, Tem) by the difference in homing potential conferred by CD62L expression 
(18).  Functional studies, however, have determined that Tcm undergo homeostatic 
proliferation and reside in secondary lymphoid tissues whereas Tem less efficiently undergo 
homeostatic proliferation but are robust producers of cytokines upon reactivation (18,19).  
Because they are found predominantly in peripheral tissues, Tem are thought to play a role 
primarily in being the front line of defense during a secondary pathogen challenge.  Unlike 
naïve CD8 T cells, memory CD8 T cells no longer require costimulation in order to be 
functional (20) and these peripherally-dwelling Tem can begin killing infected cells 
immediately.  It is thought that Tem help control the pathogen at the site of infection and Tcm 
will proliferate in response to antigen-bearing cells in secondary lymphoid tissues and help to 
increase the number of CD8 T cells available to combat the infection.   
 
CD8 T cell memory persists in the absence of pathogen so memory maintenance is not 
dependent on lingering antigen (21).  Interestingly, in chronic immune responses, a pool of 
memory CD8 T cells exists but has become anergic through repeated contact with the 
pathogen.  One of the mechanisms that the immune system uses to maintain its population of 
memory CD8 T cells is what is known as homeostatic proliferation (22,23), so-called because 
it occurs in the absence of pathogen and is proliferation that renews the pool of memory cells, 
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rather than expanding it.  In mice lacking IL-15, it was determined that adoptively transferred 
memory CD8 T cells did not undergo homeostatic proliferation and consequently memory 
CD8 T cells were lost over time (22,24).  IL-15, then, is required to drive the proliferative 
renewal of memory CD8 T cells. 
 
1.2  Interleukin 15 
Interleukin 15 is a pleiotropic cytokine that is crucial for specific cells on both the innate and 
adaptive arms of the immune system.  Initially described as a T cell growth factor, IL-15 was 
found to share many properties with IL-2 (25), not the least of which are the receptors through 
which both cytokines signal – IL-2Rβ/γc (26,27). In addition to these shared receptor 
components, IL-2 and IL-15 each have their own private binding receptors, respectively known 
as IL-2Rα and IL-15Rα (28,29).  The collective IL-2 receptors combine to achieve their high 
affinity binding (kD ~ 10−11 M) (28) while IL-15Rα by itself has very high affinity for IL-15 (1.4 x 
10−11 M ) (29,30).  In contrast to IL-2, engaging all three IL-15 receptors (IL-15Rα/IL-2Rβ/γc) 
does not enhance the binding affinity of IL-15 to its receptors (29). These biochemical 
characteristics of the interaction between IL-15 and its receptors become important when 
considering some rather unique phenomena associated with IL-15.    
 
Due to the shared usage of IL-2Rβ and the common γ-chain, both IL-2 and IL-15 induce similar 
signals in CD8 T cells.  Jak3 associates with γc and phosphorylates STAT5, which then 
dimerizes and translocates to the nucleus where it functions as a transcription factor.  Jak1 is 
associated with IL-2Rβ and phosphorylates STAT3 (reviewed in (31)).  An important STAT5 
target in CD8 T cells is the anti-apoptotic protein Bcl-2, which contributes to survival of CD8 T 
cells during an immune response (16).  Overall, because of the receptors these cytokines use 
for signaling, signaling induced by IL-2 and IL-15 is largely the same. 
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IL-2 is produced by activated T cells during immune responses and acts a potent stimulator of 
cytokine production and T cell proliferation in an autocrine and paracrine manner.  
Interestingly, screens of mRNA expression in crude sorted cell populations revealed that T 
cells did not contain IL-15 mRNA expression (27), which leads to two very important 
distinctions between IL-2 and IL-15.  Firstly, IL-15 cannot therefore function in an autocrine 
manner, and, secondly, IL-15 must be provided to T cells by a different cell.  These two crucial 
differences set the stage for the subsequent discoveries regarding the method of action for IL-
15 and serve to distinguish IL-2 and IL-15 in spite of their similar effects. 
 
Because Tregs constitutively express IL-2Rα and require IL-2 for their survival (32,33), IL-2-
deficient mice develop severe inflammation due to the lack of regulatory T cells (34).  
However, the phenotype of IL-15-deficient mice is much milder than perhaps would be 
anticipated.  Rather, the immune disruptions seen in IL-15-/- mice manifested in the 
disappearance of specific types of cells but otherwise exhibited no pathology (35).  IL-15 is not 
necessary for thymic T cell development but is necessary specifically for CD8 T cells with a 
memory phenotype, that is to say CD8 T cells expressing high levels of CD44 (35).  CD4 T 
cells are not affected by the absence of IL-15.  Though they will not be discussed at length 
here, IL-15 is also shown to be crucial for NK and NK T cell development and the development 
of CD8αα-expressing intraepithelial lymphocytes (reviewed in (36) ).  The generation of IL-
15Rα-/- mice revealed that IL-15 and IL-15Rα are intimately linked as the phenotype of mice 
lacking IL-15Rα-/- closely resembled that of IL-15-/- animals (37).  The lack of IL-15 or IL-15Rα 
mainly affects the development and/or maintenance of the aforementioned cell populations, 
suggesting that IL-15 is acting during homeostatic conditions, unlike IL-2 which is most 
typically present when there is an ongoing immune response. 
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1.3  IL-15 Transpresentation 
CD8 T cells express high levels of IL-15Rα yet it was discovered that they did not need to 
express IL-15Rα in order to respond to IL-15 (38,39).  Indeed, it was found that IL-15Rα-/- CD8 
T cells adoptively transferred into wild type (Wt) mice proliferated as well as Wt CD8 T cells, 
so long as the host they were transferred into was replete with IL-15Rα.  This observation may 
have been explained by the effects of IL-15 being indirect, i.e. the proliferation response in the 
CD8 T cells could be a byproduct of host cells being stimulated by IL-15.  IL-15, however, had 
initially been described as a T cell growth factor in vitro so the bystander explanation did not 
seem quite adequate (38).  In what would be some groundbreaking and enlightening 
experiments, it was discovered that IL-15 could actually be delivered via IL-15Rα to cells 
expressing only IL-2Rβ/γc(40).  A study using human monocytes revealed that coating these 
cells with IL-15 prior to culturing with CTLL-2 cells resulted in bioactive IL-15 as evidenced by 
thymidine incorporation, indicating there had been proliferation in the cultures (40). To buttress 
these findings, endogenously-produced IL-15 by activated monocytes expressing IL-15Rα was 
found to be sufficient to drive a response in an IL-15Rα-deficient mast cell line, PT-18, that 
expressed only IL-2Rβ/γ (40).  Because the only IL-15Rα available in this system existed on 
the monocytes, these experiments demonstrated that the response did not depend on the 
mast cells expressing IL-15Rα, rather that the cells driving the response – the activated 
monocytes – were the ones that required IL-15Rα.  These experiments were the first to 
demonstrate the presentation of IL-15 in trans and began to shed light on what had become a 
truly perplexing series of observations.  Transpresentation of IL-15 is depicted in Figure 1A, 
where IL-15 is delivered via IL-15Rα to a CD8 T cell expressing IL-2Rβ/γc. 
 
These series of experiments made strides in clarifying the role that IL-15Rα has in mediating 
IL-15 responses.  The stymieing observation that IL-15Rα was not required on CD8 T cells for  
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Figure 1.  IL-15 transpresentation by BM-derived cells  
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Figure 1.  IL-15 transpresentation by BM-derived cells.  A) Delivery of IL-15 in trans via IL-
15Rα by an unknown cell type.  The CD8 T cell responds through IL-2Rβ/γc.  B) Cartoon 
representation of various BM-derived cells and their potential to transpresent IL-15.  
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IL-15 driven responses now made sense – IL-15Rα was required to deliver IL-15, in a process 
that has since become known as IL-15 transpresentation.  IL-15 transpresentation is an 
unprecedented cytokine delivery system that remains unique and is clearly distinct from the 
vast majority of cytokines that are simply secreted.  The role of IL-15Rα as, essentially, a 
delivery mechanism also helps to explain how two virtually similar signals – IL-2 and IL-15 – 
can have discrete roles.  Therefore, the delivery of these cytokines as well as the context in 
which they are found prise apart their roles in CD8 T cell biology.   
 
Subsequent to the description of IL-15 transpresentation in vitro, several studies followed in 
short order that validated transpresentation in vivo but at the same time deepened the 
complexity already inherent in this system.  In an adoptive transfer of IL-15Rα-sufficient and –
deficient OT-I T cells, OVA-immunized mice generated and maintained normal levels of 
memory OT-I T cells (24,38); due to the host in each case being IL-15Rα sufficient, these 
studies demonstrated that transpresentation is indeed an in vivo phenomenon as well.  Using 
various bone marrow chimeras, it was discovered that not only did certain cell types require IL-
15 transpresentation, these cell types exhibited a strict preference for the nature of the cell 
providing the IL-15.  For memory CD8 T cells, IL-15Rα-/- mice reconstituted with Wt BM after 
irradiation were sufficient to fully recapitulate the memory CD8 T cell population; IL-15Rα-/- 
BM, however, failed to restore this population when transferred into Wt irradiated mice (41).  
NK and NKT T cells required transpresented IL-15 from both radiation-sensitive and –
insensitive sources whereas CD8αα+ intestinal intraepithelial lymphocytes (iIELs) required IL-
15 transpresented by radiation-resistant cells only (39).  IL-15 transpresentation, therefore, 
has very distinct roles in furnishing various immune cell niches in the variety of cells it affects 
as well as the nature of the specificity these cells exhibit for the IL-15 source.  Additionally, the 
cells that transpresent IL-15 also must synthesize it themselves: IL-15 could then effect 
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transpresentation (42).  The heterogeneity of BM-derived cells and their potential to 
transpresent IL-15 is depicted in Figure 1B. 
 
In chapter 2, I will address the issue of which specific cell type transpresents IL-15 to 
memory CD8 T cells.  Our data demonstrate that DCs transpresent IL-15 to memory CD8 
T cells mainly to drive homeostatic proliferation but DCs as well as other cells are 
involved in providing IL-15 for the survival of CD8 T cells during the contraction of an 
immune response. 
 
1.4  IL-15 Expression 
The nature of the source of transpresented IL-15 for memory CD8 T cells was found to be 
radiation-sensitive as well as BM-derived.  Given that IL-15 and IL-15Rα must be coordinately 
expressed, the cells that transpresent IL-15 must at the same time produce it. It can therefore 
be understood that IL-15 protein expression by BM-derived cells is important for memory CD8 
T cell homeostasis.  While the clarity of this observation is not in question, these findings only 
give anecdotal and indirect data that BM-derived cells express IL-15.  As the BM gives rise to 
several diverse lineages of hematopoietic cells, it is of great interest to learn what cells are 
capable of producing IL-15 as they may be candidate transpresenting cells.  Much of the 
current literature regarding IL-15 expression is confined to studies of RNA expression.  
Moreover, many such studies analyzed IL-15 mRNA after stimulation with IFN-α or Toll-like 
receptor agonists (43) and therefore were not analyzing normal, homeostatic conditions.  In 
general, very little is known about steady-state IL-15 protein expression: the current body of 
information regarding IL-15 mRNA expression is, unfortunately, largely irrelevant to the 
homeostatic conditions under which memory CD8 T cells respond to IL-15.  More to the point, 
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direct studies of IL-15 protein expression are lacking and point to a significant gap in our 
understanding of IL-15 biology. 
 
The lack of information available about IL-15 protein expression is likely a 
testament to many unsuccessful attempts that sought to determine its steady-state 
expression pattern.  Several studies have determined that at various levels, the 
stability of IL-15 mRNA as well as its translation appear to be major factors in 
regulating IL-15 expression.  Multiple isoforms of IL-15 mRNA exist, some of which 
are not transported to the cellular membrane even in the presence of IL-15Rα and 
instead are found in the nucleus and cytoplasm (44).  The presence of multiple 
AUG codons upstream of the 5’ end inhibits IL-15 mRNA translation, while yet 
other posttranslational elements exist that further interfere with IL-15 production.  
The signal peptide for IL-15 inhibits its production – when the signal peptide for IL-
2 was introduced into IL-15, IL-15 production massively increased (45).  IL-15 
production requires the presence of IL-15Rα, likely for its transport from the 
endoplasmic reticulum/Golgi apparatus to the cell surface after TLR stimulation 
(46).  While this result was not determined under homeostatic conditions, it has 
already been demonstrated that IL-15 and IL-15Rα must be co-expressed for 
various homeostatic processes so this remains a potential road block that must be 
passed before IL-15 can reach the cell surface.  Though the precise mechanism is 
unclear, it was found that IL-15 constructs containing a carboxy-terminal FLAG 
epitope resulted in far more IL-15 production than those containing the native 
carboxy-terminal sequence, leading to the conclusion that the carboxy-terminus 
includes additional negative regulation elements (45).  Overall, IL-15 is very highly 
regulated by multiple mechanisms before the mature protein is even synthesized.  
As IL-15 is a potent stimulant for CD8 T cells, these levels of regulation are likely 
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important for ensuring that IL-15 is transpresented only at appropriate times.  
Despite our understanding of what mechanisms regulate IL-15 express, very little 
is known about what constitutes “appropriate timing” for the delivery of IL-15 
signals.  The strict preference that various IL-15-dependent cell types have for the 
source of transpresented IL-15 (hematopoietic vs. parenchymal) is the best 
understanding we have of how IL-15 transpresentation is limited.  Indeed, IL-15-
responsive cells can be in IL-15+ environments but remain ignorant of the IL-15 if 
it’s not presented by the proper cell type.  Exactly how this preference is achieved 
is currently unknown. 
 
In chapter 4, I have endeavored to characterize the expression of IL-15 
among diverse hematopoietic lineages.  While IL-15 expression under 
normal, homeostatic conditions is so low that I was unable to detect it, I 
have demonstrated that IL-15 expression is increased in lymphopenic 
environments.  Additionally, I show that IL-15 is expressed by several 
previously unheralded cell types.    
 
1.5  Adhesion molecules 
Cells possess many ways of interacting with each other: indirectly, as in through 
the secretion of cytokines, or directly, via receptor:ligand interactions between two 
cells, to name two examples.  One of the ways in which direct intercellular 
interactions are achieved is through the expression of adhesion molecules, which 
interact between the opposing cells and serve to tether the cells together.  A major 
function of adhesion molecules is enabling cells to migrate between tissues via the 
bloodstream or lymphatic system.  The expression of appropriate cognate 
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adhesion molecules allows migrating lymphocytes to bind to endothelial cells, 
which express ligands for the adhesion molecules on the lymphocytes.  The 
interaction between endothelial cells and lymphocytes then enables the cell to 
migrate between endothelial cell junctions into tissues.   
 
Adhesion molecules play critical roles in the migration of cells between tissues but 
are also critical in the induction of T cell immune responses.  As mentioned 
previously, the recognition of antigen presented by MHC class I on dendritic cells 
causes the antigen-specific CD8 T cell to form lasting contacts with the dendritic 
cells.  This long-lasting contact is mediated by the expression of adhesion 
molecules on the CD8 T cell and DC that interact to bind the cells tightly together.  
CD8 T cells express the adhesion molecule LFA-1, a heterodimer composed of 
CD18 (β2) and CD11a (αL), which exists in two conformations.  In naive CD8 T 
cells, LFA-1 is expressed at relatively low levels and found in a conformation that 
has low affinity for the ligand ICAM-1, found on DCs.  Upon TCR stimulation, PLC-
γ and PKC-θ signaling can induce higher expression of LFA-1 and alter its 
conformation (47) to achieve the capability to bind ICAM-1 with high affinity. In 
addition to mediating lasting contacts between cells, adhesion molecules also 
have signaling properties.  LFA-1 contributes additional Erk1/2 signals during TCR 
stimulation and provides signals to rearrange the cytoskeleton so as to direct the 
secretion of lytic granules for CTL function (48).  For migrating CD8 T cells, the 
binding of chemokines such as CCL21 to the receptor CCR7, a G-protein coupled 
receptor, can induce the high affinity conformation of LFA-1 (49) through the 
GTPase RhoA (49).   
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CD8 T cells deficient in CD11a – one half of the LFA-1 heterodimer and thus 
lacking LFA-1 – display several deficiencies.  It was discovered that CD11a-/- OT-I 
T cells were unable to respond to low amounts of peptide compared to Wt OT-I T 
cells (50), indicating that one function of LFA-1 is to enable greater T cell 
responsiveness when peptide (antigen) is limited.  The converse argument 
therefore is that when antigen is in abundance, the role of LFA-1 may be marginal.  
The prolonged contact between DCs and CD8 T cells via LFA-1/ICAM-1 is likely 
the reason behind the efficacy of LFA-1 to foster TCR responses to limited 
antigen, enabling multiple rounds of stimulation in one interaction.  Additionally, 
CD8 T cells lacking CD11a have reduced CTL function (51), likely related to the 
inability to polarize their cytolytic granules.   
 
The large majority of literature involving the role of LFA-1/ICAM-1 in CD8 T cell 
biology is determined at the time of T cell activation but a few studies have 
investigated the impact that the lack of adhesion molecules can have in later 
phases of the CD8 T cell response.  Several models have been used to address 
this question, sometimes yielding conflicting results.  It was determined that 
although CD8 T cells express ICAM-1 as well as DCs, defects in CD8 T cell 
activation were due to the lack of ICAM-1 on DCs and not the CD8 T cells 
themselves (52).  In most cases, when ICAM-1 was absent during the induction of 
an immune response, CD8 T cell activation was impaired at low doses of antigen, 
although differing results have been reported regarding IFN-γ secretion, antigen-
driven proliferation, and cytotoxicity (7,52).  In all cases, however, ICAM-1-/- mice 
failed to generate normal levels of CD8 T cell memory, both in the frequency of 
memory cells as well as their quality (7,52).  One study followed the expansion of 
antigen-specific CD8 T cells present in the draining lymph node after immunization 
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and showed that OT-I T cells in ICAM-1-/- mice expand the same as in Wt mice but 
did not survive as well, resulting in fewer memory OT-I T cells (7).  When these 
immune mice were rechallenged, the memory OT-I T cells produced less IFN-γ 
and had decreased CTL function (7).  Similar results were obtained with the 
adoptive transfer of established OVA-specific memory CD8 T cells into ICAM-1-/- 
mice: in Wt mice, the memory cells were maintained, whereas in ICAM-1-/- hosts, 
the memory cells declined over time (53).  Though it was not linked with IL-15 
transpresentation, this study also revealed that memory CD8 T cells transferred 
into ICAM-1-/- mice had higher expression of pro-apoptotic molecules and had 
higher Annexin-V staining (53). 
 
In chapter 3 I have addressed the role of ICAM-1 and LFA-1 in IL-15 
transpresentation.  Based on the various models utilized, ICAM-1 is likely 
important for transpresentation mainly where IL-15 is limited but not where 
IL-15 is more readily available.  LFA-1, however, is highly important for the 
homeostatic proliferation of memory CD8 T cells, which may implicate that 
other adhesion molecule ligands for LFA-1 – in addition to ICAM-1 – play a 
role in IL-15 transpresentation. 
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Chapter 2 – Specific Aims 
 
2.1  The role of DCs in the transpresentation of IL-15 to memory CD8 T cells 
The source of transpresented IL-15 for memory CD8 T cell generation and homeostasis is 
known to be BM-derived but has yet to be better characterized or definitively identified.  Given 
that IL-15 transpresented requires two cells to interact, we hypothesize that DCs are the 
source of IL-15 for CD8 T cells.  By the use of a transgenic mouse model generated in our 
lab that specifically allows DCs to transpresent IL-15, we will determine the role of DCs in IL-
15 transpresentation to CD8 T cells.  IL-15 is involved in the survival of CD8 T cells during the 
contraction of an immune response as well as in the homeostatic proliferation of memory CD8 
T cells so we will use a model of an acute viral infection to study the CD8 T cell immune 
response in the transgenic mice. 
 
2.2 The requirement for adhesion molecules in IL-15 transpresentation 
In the context of antigen presentation, adhesion molecules are important for maintaining 
contact between DCs and CD8 T cells for the efficient delivery of necessary signals for CD8 T 
cell responses.  IL-15 transpresentation can be likened to this mechanism, in the sense that 
instead of antigen being presented, it is the cytokine IL-15.  We hypothesize, therefore, that 
ICAM-1 will be important for IL-15 transpresentation to memory CD8 T cells.  We will 
utilize ICAM-1-/- mice to study IL-15-related phenomena, such as the generation of CD8 T cell 
memory and homeostatic proliferation.  Because ICAM-1 is also involved in cell trafficking, we 
will use in vitro cultures to address the role of ICAM-1 in IL-15 transpresentation as well. 
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2.3 Investigation of mechanisms controlling IL-15 expression among hematopoietic 
cells 
 The observation that CD8 T cells require IL-15 transpresented by BM-derived cells invites a 
characterization of the expression patterns of IL-15 among these cell types.  As previously 
discussed, IL-15 expression is highly regulated and is a potent homeostatic cytokine.  In light 
of this, we hypothesize that steady-state IL-15 expression is very low but is likely limited 
in its breadth of expression by hematopoietic cells.  An antibody that has recently been 
demonstrated to be effective at detecting IL-15 will be used to determine both homeostatic 
and induced expression of IL-15 with the expectation that IL-15 protein expression will 
correlate with previously described mRNA expression.  Additionally, we will consider some 
mechanisms by which IL-15 expression is regulated.     
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Chapter 3 – IL-15 transpresentation by dendritic cells 
 
3.1  Introduction 
Immunological memory is an important feature of the body’s ability to ward off infections that it 
has previously encountered.  CD8 T cell memory is an integral component of said memory and 
demystifying the requirements to generate and maintain memory CD8 T cells is therefore 
critical to our understanding of how this protection arises and persists.  IL-15 is known to be 
required for these phenomena but the identity of the cell(s) that provides IL-15 for these 
processes remains unknown.  The discovery that IL-15 is transpresented by BM-derived cells 
to memory CD8 T cells narrowed down the candidate cell types but as various diverse cell 
lineages arise from the BM, a more targeted approach is necessary to more definitively 
determine the IL-15 source.   
 
3.2  Results.   
3.2.1  “CD11c promoter drives IL-15Rα expression preferentially by DCs 
Since DCs are highly specialized for T cell interactions and stimulation as well as 
express IL-15 and IL-15Rα (43,54,55), we examined the contribution of IL-15 trans-
presentation by DCs on CD8 T cell development and the generation of memory CD8 T 
cells. To target IL-15Rα to DCs, a transgenic mouse model was generated in which IL-
15Rα expression is driven by the murine CD11c promoter, a well-described promoter 
with a high specificity to DCs (56).  We chose to control IL-15Rα protein expression 
rather than IL-15 to specifically address the role of IL-15 transpresentation.  To 
eliminate IL-15Rα expression from all other cells, the CD11c-IL-15Rα Tg mice were 
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bred to the IL-15Rα-/- background. Once backcrossed, CD11c specific expression of 
cell surface IL-15Rα protein was assessed using immunofluorescence staining and 
flow cytometry.  
 
Using this approach, two founders were identified that expressed IL-15Rα by CD11c+ 
cells: one founder line with IL-15Rα restricted to CD11c+ cells and a second founder 
line with expression spilling over onto CD11c-negative hematopoietic cells.  Overall, 
the CD11c-driven expression of IL-15Rα closely correlated with the endogenous 
expression of CD11c, resulting in a model where DCs are the dominant cell type 
expressing IL-15Rα.  Analysis of transgenic IL-15Rα expression showed that IL-15Rα 
was highly expressed by lineage (CD19, CD3, DX5)-negative, CD11b+ and CD11b-
CD11chi cells (CD8+ and conventional DCs respectively) and was moderate in lin-
CD11clo (putative DC precursors and pDC) in both Tg founder lines (Figure 2A).  On 
CD11c-negative cells, which include monocytes (CD11bloSSClo), granulocytes 
(CD11bloSSChi), CD4, and CD8 T cells, Tg-1 had no expression of IL-15Rα while Tg 2 
had levels similar to that of Wt cells (Figure 2B). As NK cells and IELs express CD11c, 
each of these cell types expressed IL-15Rα in both Tg founder lines at varying levels 
(Figure2B).  Whereas previous studies have shown that IL-15Rα is expressed at a low 
level on CD11c+ cells (57), a comparison of IL-15Rα expression by DC subsets 
directly ex vivo had not been described before.  Interestingly, this analysis 
demonstrates that IL-15Rα expression is relatively low and homogenous among DC 
subsets and other myeloid cells.  
A similar technique was used to measure IL-15 on the cell surface using a recently 
available antibody.  On lineage-negative myeloid cells, cell surface IL-15 was detected 
on CD11b+ and CD8+CD11c+ cells (DCs) at similar levels in both Wt, Tg1, and Tg2  
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Figure 2. Expression of IL-15 and IL-15Rα in CD11c-IL-15Rα Tg mice 
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Figure 2. Expression of IL-15 and IL-15Rα in CD11c-IL-15Rα Tg mice 
(A) Histograms show IL-15Rα expression on myeloid subsets in Wt, CD11c-IL-15Rα 
Tg 1 and Tg 2, and IL-15Rα-/- mice after gating on lineage (CD3, CD19, DX5) negative 
splenocytes. Filled histograms indicate IL-15Rα staining on the indicated populations, 
open histograms represent staining of the same population from IL-15Rα-/- mice.  (B) 
Histograms show IL-15Rα staining on lymphoid populations from the spleen (top three 
panels) and IEL (bottom three panels). (C, D) 1x107 splenocytes from Wt, CD11c/IL-
15Rα Tg 2, and IL-15-/- mice were cultured overnight in CM prior to staining.  Filled 
histogram indicates IL-15 staining, the open histogram represents staining of cells from 
IL-15-/- mice. Histograms in panel C were first gated on lineage-negative cells as in 
panel A.   (E) Splenocytes were treated as in C in the absence or presence of 1µg/ml 
LPS.  This research was originally published in Blood. Stonier, S.W., Ma, L.J., 
Castillo, E.F., and Schluns, K.S. Dendritic cells drive memory CD8 T-cell homeostasis 
via IL-15 transpresentation. Blood. 2008; 112:4546-4554. © the American Society of 
Hematology.(58)    
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cells, although was not present on pDCs (Figure 2C). In WT and Tg 2 but not Tg 1 
mice, IL-15 expression was observed at a lower level on CD11b+CD11c- cells 
(monocytes and granulocytes) (Figure 2C) providing evidence that cells other than DCs 
may transpresent IL-15.  Among lineage+ cells (CD4 T cells, CD8 T cells, B cells, or NK 
cells), IL-15 was not detected on the surface of cells isolated from WT or either CD11c- 
IL-15Rα Tg mice (Figure 2D).  In response to LPS stimulation, the amount of IL-15 
upregulated was similar in DCs from both WT and Tg mice (Figure 2E) suggesting that, 
in spite of elevated IL-15Rα on DCs, IL-15 expression was not coordinately enhanced.  
Altogether, these findings demonstrate that DCs and monocytes/granulocytes express 
cell surface IL-15 in WT mice; however, DCs in the CD11c-IL-15Rα Tg-1 mice are 
likely the only cell transpresenting IL-15.   
 
3.2.2   Naïve and memory-phenotype CD8 T cells are partially recovered in the 
presence of IL-15Rα+ DCs 
IL-15Rα-/- mice have reduced numbers of peripheral CD8 T cells with the deficiency in 
memory-phenotype CD8 T cells affected more than the naïve CD8 T cells (37). 
Decreased numbers of naïve CD8 T cells in the absence of IL-15Rα are predominantly 
due to the decreased survival of naïve CD8 T cells as only minor effects on the thymic 
CD8 T cells are observed (59). To determine if CD11c-driven IL-15Rα affects thymic T 
cell development, thymocytes were analyzed from the CD11c-IL-15Rα Tg mice and 
compared to IL-15Rα-/- and Wt mice.  The proportions of the major thymocyte subsets 
(CD4-CD8-, CD4+CD8+, CD4+, and CD8+ thymocytes) were similar in all groups of 
mice (Figure 3A, and data not shown) indicating that transgenic expression of IL-15Rα 
does not cause major disruptions in thymic T cell development.    
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Figure 3.  Phenotype of CD8 T cells as a function of CD11c-driven IL-15Rα expression.    
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Figure 3.  Phenotype of CD8 T cells as a function of CD11c-driven IL-15Rα 
expression.  Lymphocytes from thymus, spleen (SP), lymph node (LN), lung (LG), and 
bone marrow (BM) were isolated from the mice indicated (6-8 week old) and stained for 
cell surface markers to identify differences in T cell populations. (A) Representative 
flow cytometry plots from thymus and spleen.  (B) The percentage of CD8 T cells along 
with the proportion of naïve (CD44low) and memory-phenotype (CD44hi) in various 
tissues. Results are averages with n=10 mice/group for Tg-1. For Tg-2, n=8 for spleen 
and n=2 for other tissues.  § represents a significant difference between naïve T cells 
in Tg and Wt (P<0.05) while * indicates differences between memory phenotype in Tg 
and Wt (p<0.05). (C) The number of each IEL population recovered from small 
intestine of the indicated mice.  The respective populations were identified after gating 
on CD45+ cells. Error bars represent SD from a representative experiment; values 
from either Tg mice are not significantly different than those from IL-15Rα-/- mice.  (D) 
Total numbers of myeloid populations in the spleen of the indicated mice.  Error bars 
represent SD, n=2, for one representative experiment. This research was originally 
published in Blood. Stonier, S.W., Ma, L.J., Castillo, E.F., and Schluns, K.S. Dendritic 
cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood. 2008; 
112:4546-4554. © the American Society of Hematology.(58)    
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Upon extending our analysis to peripheral tissues, differences in the CD8 T cells 
between the different groups of mice were apparent.  As previously reported, the 
percentage of CD8 T cells in the IL-15Rα-/- mice are decreased by approximately 50% 
compared to Wt mice (37), a trend observed not only in the spleen but also in the 
lymph node, lung, and bone marrow (Figure 3A, B).  In both CD11c-IL-15Rα Tg lines, 
the percentages of splenic CD8 T cells were increased compared to those observed in 
the IL-15Rα-/- mice (~9% and 11% compared to only ~6%), but lower that in the Wt 
mice (~12%)(Figure 3A, B). This trend was consistently seen in the other tissues 
analyzed.  Since the total CD8 T cell population is comprised of both naïve and 
memory-phenotype CD8 T cells and IL-15 preferentially affects the memory CD8 T 
cells (54), the effects of the restricted IL-15Rα expression on these two subpopulations 
was measured.  For the naïve CD8 T cells (CD44low), the presence of IL-15Rα+DCs in 
Tg 1 increased the percentage of naïve CD8 T cells from ~50%, as observed in IL-
15Rα-/- mice, to between 62-71% of Wt values, depending on the tissue (Figure 3B); 
however, this effect was more dramatic in the Tg2 line where the percentages of naïve 
T cells were almost similar to levels seen in Wt mice.  Among total CD8 T cells, 
percentages of memory-phenotype (CD44hi) CD8 T cells in the CD11c-IL-15Rα Tg 
mice approached parity with Wt levels in all tissues examined, ranging from 90-100% 
of Wt in both Tg lines(Figure 3B). Although the percentage of memory-CD8 T cells is 
almost recovered, a deficiency in the total levels of memory CD8 T cells still exists as a 
function of the deficit in naïve CD8 T cells in CD11c-IL-15Rα Tg mice (Figure 3B).  
Altogether, these findings show that that the CD11c-IL-15Rα transgenic environment 
partially restored the deficiencies in total CD8 T cells observed in the IL-15Rα mice 
with the memory-phenotype CD8 T cells affected more than the naïve CD8 T cells. 
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Intestinal IELs, specifically TCRγδ and CD8ααTCRαβ cells, depend heavily on IL-15 for 
their normal development (37).  To determine whether CD11c-driven expression of IL-
15Rα+ affects IEL development, IELs were isolated from each group of mice and the 
respective populations were compared.  Similar to IL-15Rα-/- mice, CD11c-IL-15Rα Tg 
1 and 2 mice were deficient in TCRγδ and CD8ααTCRαβ cells, whereas conventional 
CD8ααTCRαβ cells were present in normal numbers (Figure 3C).  While there are 
clearly IL-15Rα+ cells present in the intestines, the inability of these cells to recover the 
defects in IEL development is a sterling example of how cell specificity dictates 
responsiveness to transpresented IL-15. 
 
Since IL-15Rα expression by DCs could indirectly affect CD8 T cell development by 
altering the development and normal function of DCs, general characteristics of DCs 
were examined. Among lineage negative cells, no differences in the number or 
distribution of various DC subsets were observed in spleen (Figure 3D) among the four 
groups of mice.  In addition, MHC class II expression by CD11chiDCs was not different 
(data not shown).  Altogether, elevated IL-15Rα expression did not alter the 
development or maturation of DCs. 
 
3.2.3   IL-15Rα expression by DCs contributes to the generation of virus-specific 
memory CD8 T cells  
We next measured the generation and maintenance of antigen-specific memory CD8 T 
cells in response to a viral infection in our transgenic system.  In separate experiments, 
Wt, CD11c-IL-15Rα Tg-1, Tg-2, and IL-15Rα-/- mice were infected with 1x105 pfu VSV 
(vesicular stomatitis virus) and the levels of N-tetramer+ CD8 T cells in the peripheral 
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blood were measured at various times post-infection.  During the expansion phase, no 
detectable differences in the percent of VSV-specific T cells were observed between 
the groups of mice (Figure 4A), which is consistent with previous studies showing IL-
15Rα is not required for normal Ag-specific CD8 T cell expansion (22,24).  Following 
the contraction phase (30 days p.i.), the percentage of VSV-specific CD8 T cells 
present in the blood was increased in the CD11c-IL-15RαTg-1 mice, compared to IL-
15Rα-/- mice, but was lower than that of Wt mice (Figure 4A), which was in contrast to 
Tg-2 mice, which had levels similar to Wt mice (Figure 4B).  During the memory phase, 
both CD11c-IL-15Rα Tg mice were able to maintain levels of VSV-specific CD8 T cells 
similar to Wt mice (Figure 4A,B). The discrepancy between the two Tg mice can be 
explained by the leaky expression of IL-15Rα expression onto CD11c-negative cells, 
therefore suggesting that transpresentation by cells other than DCs participate in 
providing IL-15 to CD8 T cells during the contraction phase. 
 
To determine if tissue-specific effects were evident, the level of VSV-specific CD8 T 
cells was measured in the spleen, lymph nodes, and lung.  In all the tissues analyzed, 
the percent of VSV-specific memory CD8 T cells in CD11c-IL-15Rα Tg-1 was greater 
than in the IL-15Rα-/- mice, but less than in the Wt mice (Figure 4C).  When IL-15Rα is 
present on both CD11c+ and CD11c- cells (Tg-2), the percentage of viral-specific CD8 
T cells in the tissues was similar to that of Wt mice (Figure 4D). As expected, due to 
pre-existing defects in total CD8 T cells, total numbers of Ag-specific CD8 T cells were 
also deficient (Figure 4E and data not shown).  Overall, the effect of transpresentation 
by DCs in different tissues was commensurate to the trends observed in the blood, 
indicating no tissue-specific effects.  
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CD27, KLRG-1, IL-7Rα, CD62L are cell surface markers that have been used to define 
subpopulations of effector and memory CD8 T cells(14,15,60).  During the transition 
from effector to memory T cell, CD27+ KLRG-1-, IL-7Rαhi CD8 T cells have been 
identified as those having a greater potential to differentiate into memory T cells.  In 
contrast, KLRG-1+CD27-IL-7Rα- cells are thought to represent short-lived effectors 
that rely temporarily on IL-15 for their survival (15). Therefore, to determine whether IL-
15Rα+ DCs alter the differentiation of these subsets, expression of CD27, KLRG-1, 
and IL-7Rα by antigen-specific CD8 T cells was analyzed at various times after 
infection in the CD11c-IL-15Rα Tg-1 mice.  We chose to use the combination of CD27 
and KLRG-1 as CD27+ KLRG-1- cells were more easily defined than IL-7Rα+ KLRG-1- 
cells. At the peak of the expansion (7 days p.i.), no differences in the proportion of 
VSV-specific CD8 T cells defined by KLRG-1 and CD27 were observed between the 
different groups (Figure 4F).  Interestingly, from 19-60 days p.i., the VSV-specific CD8 
T cells in the IL-15Rα deficient mice were predominantly CD27-KLRG-1+ whereas both 
CD27+ KLRG-1+ and CD27+KLRG-1- populations were abundant at similar levels in 
both the CD11c-IL-15Rα and Wt mice (Figure 4F). Considering all memory CD8 T cells 
utilize IL-15, our findings suggest that IL-15Rα+ DCs preferentially drive the survival of 
short-lived CD27- KLRG-1+ memory T cells while other IL-15Rα+ cells may promote 
development of long-lived memory CD8 T cells.  
Whereas KLRG-1, CD27 and IL-7Rα identify T cell subsets during the transition from 
the effector phase to the memory phase, high CD62L expression on a subset of 
memory T cells is associated with the ability to migrate to lymphoid tissues and an 
enhanced self-renewal, i.e. central memory (18,61). To determine whether CD11c-
directed expression of IL-15Rα affects the generation of central and effector memory 
subsets, CD62L expression on VSV-specific memory CD8 T cells was examined.   
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 Figure 5. Role of IL-15Rα+ DCs in a viral immune response. 
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Figure 5. Role of IL-15Rα+ DCs in a viral immune response. 
The kinetics of an anti-viral CD8 T cell response was compared among different groups 
of mice by measuring the percent of VSV-specific CD8 T cells present in the peripheral 
blood as determined by N-tetramer staining: (A) CD11c-IL-15Rα Tg-1, (B) CD11c-IL-
15Rα Tg-2. (C,D) Dot plots show the percent of N-tetramer+ cells versus CD44 
expression after gating on CD8+ cells present in SP, LN, and LG 25 weeks p.i. in C) 
Tg-1, and (D) Tg-2. (E) Graphs show total numbers of N-tet+ cells recovered from the 
various tissues in Wt, Tg 1 and IL-15Rα-/- mice. Error bars represent SD, n=2. Numbers 
above the bars represent percent of Wt mice.  (F) KLRG-1 and CD27 expression on N-
tet+ CD8 T cells in peripheral blood at indicated times after infection.  (G) Histograms 
show CD62L expression by N-tet+ CD8 T cells in various tissues 25 weeks p.i.. This 
research was originally published in Blood. Stonier, S.W., Ma, L.J., Castillo, E.F., 
and Schluns, K.S. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 
transpresentation. Blood. 2008; 112:4546-4554. © the American Society of 
Hematology.(58)    
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Depending on the tissue site of isolation, VSV-specific memory CD8 T cells had a 
similar pattern of CD62L expression among all groups of mice (Figure 4G and data not 
shown). This suggests that IL-15Rα did not impact the proportion of memory CD8 T 
cell subsets, as defined by CD62L expression, that arise during an acute viral infection.   
 
3.2.4   IL-15Rα+ DCs drive homeostatic proliferation of memory CD8 T cells 
Whereas we demonstrated that IL-15Rα+ DCs alone were not completely sufficient in 
generating normal levels of memory CD8 T cells, it was unclear whether IL-15Rα+ DCs 
could still drive normal homeostatic proliferation. To examine the homeostatic 
proliferation of endogenous Ag-specific memory CD8 T cells, VSV-infected mice from 
each group (Wt, CD11c-IL-15Rα Tg 1, and IL-15Rα-/-) were given BrdU in their drinking 
water at 40 days p.i. for 4 weeks.  After this course of treatment, BrdU incorporation of 
the VSV-specific memory CD8 T cells in various tissues was measured. In all the 
tissues analyzed, VSV-specific CD8 T cells incorporated similar levels of BrdU in 
CD11c-IL-15Rα Tg 1 and Wt mice (Figure 5A).  In contrast, VSV-specific memory CD8 
T cells had little BrdU incorporation in the IL-15Rα-/- mice. Although the extent of BrdU 
incorporation was slightly different among tissues, the effect of the transgenic IL-
15Rα+ by DCs drove almost normal levels of cell division. The similar BrdU 
incorporation in VSV-specific memory CD8 T cells between Wt and CD11c-IL-15Rα Tg 
1 mice is evidence that IL-15Rα+ DCs are pivotal in mediating homeostatic 
proliferation of memory CD8 T cells.  
 
The possibility exists that the ability of memory CD8 T cells to undergo homeostatic 
proliferation is affected earlier in the immune response by the transgenic expression of  
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 Figure 4. Homeostatic proliferation of memory CD8 T cells.  
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Figure 4. Homeostatic proliferation of memory CD8 T cells.  
(A) Histograms show the percentage of VSV-N specific memory CD8 T cells that have 
incorporated BrdU.  (B) Spleen cells from normal, CD45.1+, VSV-infected mice were 
enriched for CD8 T cells, labeled with CFSE, and transferred to various CD45.2+ hosts. 
Two months after transfer, lymphocytes from SP, LG, and BM were analyzed for CFSE 
intensity. Top panels show CFSE dilution in CD45.1+ CD44hi CD8+ T cells (memory-
phenotype) in various tissues.  Bottom row depicts CFSE dilution in splenic N-tet+ 
cells.  This research was originally published in Blood. Stonier, S.W., Ma, L.J., 
Castillo, E.F., and Schluns, K.S. Dendritic cells drive memory CD8 T-cell homeostasis 
via IL-15 transpresentation. Blood. 2008; 112:4546-4554. © the American Society of 
Hematology.(58)    
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IL-15Rα.  We therefore examined the proliferation of VSV-specific memory CD8 T cells 
generated in a normal environment. CD8 T cells were enriched from congenic Wt mice 
(CD45.1+) previously infected with VSV, CFSE-labeled, and adoptively transferred into 
CD11c-IL-15Rα Tg-1, Wt, and IL-15Rα-/- mice (all CD45.2+).  Approximately two 
months later, CFSE dilution of the donor CD8 T cells was measured.  In both the Tg 
and Wt mice, the memory-phenotype CD8 T cells divided 2-3 times in the spleen, lung, 
and lymph node in a similar manner (Figure 5B). Similar results were observed with 
CD11c-IL-15Rα Tg-2 line (data not shown).  In contrast, the IL-15Rα-/- host was unable 
to support division of the memory-phenotype CD8 T cells (Figure 5B).  Among the 
VSV-specific memory CD8 T cells and memory CD8 T cells in the BM, both the Wt and 
Tg mice were able to induce cell division; however, cell division was greater in the Wt 
than in the Tg hosts (Figure 5B). Overall, the exclusive expression of IL-15Rα to DCs 
provides a sufficient signal for memory CD8 T cells to proliferate under homeostatic 
conditions.  
 
3.2.5   IL-15Rα+ DCs are not the only hematopoietic cells participating in 
homeostatic proliferation of memory CD8 T cells 
The homeostatic proliferation of memory CD8 T cells was almost completely recovered 
in mice that express IL-15Rα exclusively by CD11c+ cells (Figure 6B), indicating that 
other cells types transpresent IL-15 to memory CD8 T cells.  Since our previous 
studies showed that IL-15Rα by parenchymal cells could play a minor role in 
homeostatic proliferation (41), we wanted to determine if a host containing IL-15Rα+ 
DCs along with IL-15Rα+ parenchymal cells would be sufficient to completely restore 
the homeostatic proliferation of memory CD8 T cells.  Therefore, three groups of BM 
chimeras were generated with each group containing different combinations of IL-15Rα 
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on either DCs and/or parenchymal cells: 1) Wt BM in Wt hosts (IL-15Rα expressed by 
all cells), 2) CD11c-IL-15RTg-1 in Wt hosts (IL-15Rα expressed by DCs and 
parenchymal cells), 3) IL-15Rα-/- BM in Wt hosts (IL-15Rα expressed only by 
parenchymal cells).  After reconstitution, CD8 T cells (~10x106) from a cohort of VSV-
infected Thy1.1+ mice (at least 40 days p.i.) were isolated, labeled with CFSE, and 
transferred into the various groups of chimeras.  Six weeks later, homeostatic 
proliferation of the donor memory CD8 T cells was assessed by measuring CFSE 
dilution. Memory CD8 T cells divided 1-3 times in the Wt chimeras (Wt into Wt) 
representing the normal level of homeostatic proliferation over this time-period (Figure 
5).  In the chimeras containing IL-15Rα+ DCs along with IL-15Rα+ parenchymal cells 
(CD11c-IL-15RαTg-1 into wt), the memory CD8 T cells divided but not to same extent 
as in the Wt chimeras (Figure 6).  Little cell division of memory CD8 T cells was 
observed in the chimeras containing IL-15Rα only in the parenchyma (IL-15Rα-/- into 
Wt) (Figure 5). These differences indicate that homeostatic proliferation of memory 
CD8 T cells is not completely restored in the presence of IL-15Rα+ DCs and 
parenchymal cells and suggest that IL-15Rα+ hematopoietic cells other than DCs 
participate in the response.    
 
3.3   Discussion 
Generating a model with DC-restricted IL-15Rα expression has allowed us to 
demonstrate that DCs are not only important for presenting antigen for T cell 
stimulation but also for presenting IL-15 during later stages of CD8 T cell 
differentiation.  This function of DCs in memory CD8 T cell homeostasis had been 
speculated but never demonstrated. Our study has also demonstrated that IL-15 
transpresentation by DCs has specific roles during CD8 T cell differentiation in that 
DCs were most effective at inducing homeostatic proliferation of established memory  
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 Figure 6. Contribution of CD11c-negative hematopoietic cells in memory CD8 T 
cell homeostasis. 
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Figure 6. Contribution of CD11c-negative hematopoietic cells in memory CD8 T 
cell homeostasis. BM cells were isolated from IL-15Rα-/-, CD11c-IL-15RαTg-1, and 
Wt mice (all CD45.2+) and transferred into lethally irradiated Wt hosts (CD45.1+).  CD8 
T cells were isolated from VSV-infected Thy1.1+ cells, labeled with CFSE, and 
transferred into the various BM chimeras after lymphocyte reconstitution (between 8-12 
weeks after BM transfer).  Six weeks after transfer, CFSE dilution of donor cells was 
measured.  This research was originally published in Blood. Stonier, S.W., Ma, 
L.J., Castillo, E.F., and Schluns, K.S. Dendritic cells drive memory CD8 T-cell 
homeostasis via IL-15 transpresentation. Blood. 2008; 112:4546-4554. © the 
American Society of Hematology.(58)    
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CD8 T cells, while having less of a role in generating memory CD8 T cells and the 
homeostasis of naïve CD8 T cells. In contrast, transpresentation by DCs had no effect 
on IEL development.  In concurrent analysis of our model, we have also found that IL-
15 transpresentation by DCs heavily influenced NK cell development while only 
minimally affecting NKT cell development (62). Altogether, our study has shown that 
cell specificity is pivotal in dictating IL-15 responsiveness by transpresentation and that 
DCs are an integral cell type transpresenting IL-15 to memory CD8 T cells. 
 
The enhanced ability of DCs to transpresent IL-15 as differentiation progresses could 
be an indication that developing memory CD8 T cells become more accessible to DCs 
and preferentially receive IL-15 signals in a DC-enriched environment.  This is 
contradictory to studies touting BM as the predominant site for memory CD8 T 
homeostasis, as BM is a site with a very low frequency of DCs. The importance of BM 
in providing homeostatic signals is based on the presence of memory CD8 T cells 
undergoing a higher rate of cell division (63-65), which could be explained by 
preferential migration of actively dividing central memory CD8 T cells.  If BM is the 
predominant site for memory CD8 T homeostasis, we would predict an exaggerated 
defect in homeostatic proliferation of memory CD8 T cells in the BM of our Tg model, 
where only DCs transpresent IL-15.  On the contrary, homeostatic proliferation of 
memory CD8 T cells was restored rather efficiently in the BM of the CD11c-IL-15Rα Tg 
mice suggesting that memory CD8 T cells did receive adequate IL-15 signals 
elsewhere and then preferentially migrated to the BM.  Moreover, memory CD8 T cells 
that are sequestered in the spleen and LN with FTY720 treatment undergo normal 
homeostatic proliferation despite this tissue restriction (66). This result, along with our 
findings, suggest that memory CD8 T cells efficiently receive homeostatic signals in 
many tissues besides the BM. 
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In addition to the specific effects on the homeostatic proliferation of established 
memory CD8 T cells, DCs appeared to have a distinct role in generating memory CD8 
T cells. During the contraction phase, IL-15 begins to become important by mediating 
survival of Ag-specific CD8 T cells as these cells are not proliferating (67).  Specifically, 
a subpopulation of short-lived effectors (SLECs) defined as KLRG-1+, are 
predominantly affected by the lack of IL-15 (68).  In our model, IL-15 transpresentation 
by DCs limited the contraction of the Ag-specific memory CD8 T cells by increasing the 
proportion of SLEC-like cells. Considering all memory CD8 T cells utilize IL-15, our 
findings yield two possible scenarios: SLECs may be more responsive or accessible to 
DCs providing IL-15. 
 
The limited requirements for DCs transpresenting IL-15 to naïve and differentiating 
memory CD8 T cells highlights the idea that cells other than DCs are providing IL-15 to 
CD8 T cells during these earlier phases.  For naïve CD8 T cells, this isn’t surprising as 
previous studies using BM chimeras indicated that IL-15Rα expression by parenchymal 
cells is important for naive CD8 T cells (41).  Our current studies provide further 
evidence for this, as the ability to generate a normal frequency of naïve CD8 T cells 
could not be substituted by CD11c+ and/or CD11c- hematopoietic cells even when IL-
15Rα is expressed at high levels.  For differentiating memory CD8 T cells, these cells 
do not appear to utilize IL-15 transpresented by parenchymal cells but rather receive 
IL-15 signals from both CD11c+ and CD11c- hematopoietic cells.  In comparison of the 
two CD11c-IL-15Rα Tg lines, the main difference observed was during the contraction 
phase.  When IL-15Rα expression was restricted to DCs, the contraction of the Ag-
specific CD8 T cells was more exaggerated resulting in less memory CD8 T cells 
generated; however, when IL-15Rα expression was present on DCs along with other 
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hematopoietic cells, the contraction and generation of memory CD8 T cells was 
normal.  Therefore, our study provides the first evidence that some unknown CD11c-
negative hematopoietic cells participate in the generation of memory CD8 T cells in 
vivo.     
 
The incomplete abilities of DCs to transpresent IL-15 to CD8 T cells was not only 
present during the generation of memory CD8 T cells, but could also be observed to a 
small degree during the homeostasis of memory CD8 T cells. While parenchymal cells 
can have a minor contribution in homeostatic proliferation (41), the combination of IL-
15Rα on both DCs and parenchyma did not completely restore normal levels of 
homeostatic proliferation, again providing evidence that hematopoietic cells other than 
DCs transpresent IL-15 to memory CD8 T cells during the memory phase.   
 
 
While this current study has provided evidence that other hematopoietic cells 
transpresent IL-15 to CD8 T cells, the clear effectiveness of the DCs suggests that 
DCs may be superior at IL-15 transpresentation than other cell types; however, this 
could have been due to the imprecise specificity of the transgenic promoter.  Whereas 
high expression of CD11c is specific to DCs, low levels of CD11c are sometimes 
expressed on non-DCs, such as activated T cells, NK cells, and IELs (69).  In our Tg 
models, even when some IL-15Rα is expressed on these cells, it was not accompanied 
by IL-15 expression. As IL-15 is not transferred from other transpresenting cells even 
under inflammatory circumstances (46), this IL-15Rα does not appear to be 
transpresenting IL-15.  Furthermore, since previous studies have shown that IL-15Rα 
expression by T cells is dispensable for generation and maintenance of memory CD8 T 
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cells and the IL-15 dependent development of IELs (39,41,70), the little IL-
15Rα expression that is expressed by T cells is likely irrelevant. 
 
Another caveat of our model is the supraphysiological levels of IL-15Rα present on 
DCs that could make the DCs more efficient.  Indeed, recent reports demonstrate that 
the presence of IL-15Rα can stabilize IL-15 protein and increase bioactivity (71); 
however, our studies do not support the idea that higher IL-15Rα translates to more IL-
15 transpresentation as IL-15RαhiDCs did not have higher levels of IL-15 than IL-
15RαloDCs.  Altogether, our observations suggest that IL-15 expression appears to be 
endogenously controlled and is the limiting factor in transpresentation. 
 
In summary, we have developed an in vivo model whereby DCs are likely the only cell 
able to transpresent IL-15.  Using this model, DCs are shown to be effective in 
mediating the generation and maintenance of memory CD8 T cells via IL-15 
transpresentation, thus identifying a novel function of DCs.  Although efficient at 
transpresenting IL-15 to memory CD8 T cells, DCs were not the only hematopoietic 
cells acting on memory CD8 T cells. Lastly, the inability of IL-15 transpresented by DCs 
to recover all the IL-15 functions in CD8 T cells is a sterling example of how cell 
specificity dictates responsiveness to transpresented IL-15.  In general, these findings 
will enable future studies to better focus on mechanisms regulating T cell homeostasis.  
This research was originally published in Blood. Stonier, S.W., Ma, L.J., Castillo, E.F., and 
Schluns, K.S. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. 
Blood. 2008; 112:4546-4554. © the American Society of Hematology."”(58)    
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A study conducted by Mortier et al used another system to analyze cell-specific IL-15 
transpresentation (72).  In this model, Cre-lox technology was employed to remove the ability 
to transpresent, in contrast to our model which bestowed this ability.  Their findings largely 
mirrored ours: when recombination and deletion in IL-15Rα-loxp mice was directed by CD11c-
Cre mice, memory CD8 T cells declined over time (72).  Homeostatic proliferation was not 
measured in these mice, only the frequency of OT-I T cells in the blood.  Nonetheless, their 
findings corroborated ours in that DCs are important in transpresenting IL-15 for memory CD8 
T cell maintenance.  Additionally, LysM-Cre x IL-15Rα-loxp mice exhibited a partial recovery of 
antigen-specific, contracting CD8 T cells; in these mice the lack of transpresentation is due to 
the absence of IL-15Rα on macrophages, although LysM promoter usage is not strictly limited 
to macrophages (72).  Therefore, our study showed that DCs alone were not sufficient to fully 
protect contracting CD8 T cells, and the study by Mortier et al suggests that macrophages are 
the other side of the coin, so to speak.    
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Chapter 4 – ICAM-1 and IL-15 transpresentation 
 
4.1  Introduction 
 
The transpresentation of IL-15 requires close contact between cells.  The nature of 
transpresentation being an intercellular interaction – at a basic level – then likely also involves 
the adhesion of transpresenter to responder.  How long this interaction lasts, and whether or 
not several “transpresentation events” occur during one interaction, are large unknowns in the 
field.  Additionally, the requirements for this interaction have never been addressed in regards 
to what molecules are required on the cell surface to manufacture or maintain the interaction.   
 
Given that IL-15Rα is not expressed in high amounts on the surface of DCs – or any other 
myeloid cell type for that matter – and the fact that IL-2Rβ/γc are not highly expressed either, it 
stands to reason that a cellular interaction generated solely by IL-15 transpresentation is a 
poor basis for two cells to interact.  Therefore, we propose that adhesion molecules – 
specifically, ICAM-1 and LFA-1 – are important for IL-15 transpresentation.  In this scenario, 
cells would first likely interact via adhesion molecule receptor:ligand pairings, which would 
then enable IL-15 transpresentation.  As memory CD8 T cells express high amounts of LFA-1 
and require IL-15 for their maintenance, the high expression of LFA-1 may be a feature that 
gives them additional ability to interact with cells transpresenting IL-15.  It has already been 
demonstrated that mice lacking ICAM-1 fail to support CD8 T cells during the contraction of an 
immune response and subsequently generate lower levels of memory (7).  This pattern is 
reminiscent of IL-15Rα-/- mice, which may suggest a relationship between ICAM-1 and IL-
15Rα.  Therefore, we have set out to investigate the role of ICAM-1/LFA-1 in IL-15 
transpresentation to memory CD8 T cells. 
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4.2.  Results 
 
4.2.1  BMDCs need ICAM-1 to transpresent IL-15 to memory CD8 T cells 
 
Because ICAM-1 is involved in cell trafficking as well as antigen presentation, we first looked 
for evidence that ICAM-1 plays a role in IL-15 transpresentation in a closed system where 
migration would not be a factor.  To address this, cultures of CD8 T cells and BM differentiated 
DCs were utilized as a model of IL-15 transpresentation in isolation, enabling the study of IL-
15 transpresentation while avoiding any potential unforeseen effects due to altered migration. 
To investigate IL-15 responses in vitro, CD8 T cells were enriched from congenically-marked 
mice and cultured in the presence of BrdU with poly I:C-activated bone marrow-differentiated 
DCs (BMDCs) from Wt and ICAM-1-/- BM.  After three days of culture, the frequency of CD44hi 
CD8 T cells was higher among CD8 T cells cultured with Wt DCs compared to ICAM-1-/- DCs 
(Figure 7A), showing that survival of memory CD8 T cells required ICAM-1 expression by DCs.  
More importantly, BrdU incorporation was apparent only among CD44hi CD8 T cells (~22% of 
CD44hi) cultured with Wt DCs, demonstrating a response specific to memory phenotype CD8 T 
cells (Figure 7A,B).  In contrast, BrdU incorporation was virtually absent in CD44hi CD8 T cells 
cultured with ICAM-1-/- DCs (Figure 7A,B).  Memory CD8 T cells also failed to incorporate 
BrdU when cultured with Wt DCs in the presence of ICAM-1 and CD122 blocking Ab or DCs 
generated from IL-15Rα-/- BM (Figure 7C,D).  These findings provide evidence that BrdU 
incorporation in this system is indeed mediated by IL-15 and not related to development 
differences in DCs generated from IL-15Rα-/- or ICAM-1-/- mice.  Given that BrdU incorporation 
was confined to memory CD8 T cells and dependent on IL-15Rα by DCs (Figure 7C,D), these 
results demonstrate the  
48 
 
Figure 7.  BrdU incorporation in memory CD8 T cells requires IL-15Rα and ICAM-1 
expression by BMDCs.    
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Figure 7.  BrdU incorporation in memory CD8 T cells requires IL-15Rα and ICAM-1 
expression by BMDCs.  A) Top row show shows percent of memory CD8 T cells (CD44hi) on 
TCRβ+ CD8α+ CD45.1+ gated cells present after coculturing with Wt or ICAM-1-/- BMDCs.  
Bottom row shows percent of cells incorporating BrdU, gated as above.  Plots are 
representative of 2 replicates per group. B) Histograms show the average BrdU incorporation 
in CD44hi CD8 T cells. Error bars represent SD of 2 replicates per group.  C) Representative 
flow cytometric plots show BrdU incorporation in CD8 T cells cocultured with BMDC in the 
presence of the indicated Ab.  D) Graph shows the average BrdU incorporation in CD44hi CD8 
T cells. Error bars represent SD of 2 replicates per group.  Data is representative of 3 
independent experiments. 
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importance of ICAM-1 in a response mediated by IL-15 transpresentation.  We also 
differentiated DCs using BM from β2m-/- mice to determine if MHC class I expression was  
involved in this proliferation response.  To our surprise, CD8 T cells cocultured with β2m-/- 
BMDCs failed to proliferate (Figure 8), resembling cocultures with both IL-15Rα-/- and ICAM-1-/- 
BMDCs.  MHC class I expression, therefore appears to be important in this coculture system, 
though exactly what role it plays is unclear. 
 
Because of the lack of BrdU incorporation among memory phenotype CD8 T cells cultured 
with ICAM-1-/- BMDCs, we next asked if IL-15 signaling was compromised in CD8 T cells after 
culture with ICAM-1-/- DCs.  To this end, serum-starved CD8 T cells were cocultured with poly 
I:C-activated BMDC for 1h and then analyzed for STAT5 phosphorylation, a major signaling 
event induced by IL-15 (73,74).  CD8 T cells cultured in the absence of DCs show virtually no 
pSTAT5 expression whereas CD8 T cells cultured with rIL-15 showed a dramatic induction of 
pSTAT5 expression, in both the memory and naïve populations.  When cultured with Wt DCs, 
the CD8 T cells showed a clear increase in pSTAT5 expression (Figure 9A,B) with the CD44hi 
CD8 T cells expressing higher levels of pSTAT5 than CD44lo CD8 T cells (39% compared to 
15%, respectively), which again is consistent with memory CD8 T cells being more responsive 
to IL-15 signals (54).  In striking contrast, the induction of pSTAT5 signaling was severely 
impaired in both memory and naïve CD8 T cells when cultured with BMDCs derived from IL-
15Rα-/- or ICAM-1-/- BMDC (Figure 9A,B).  These data demonstrate that the absence of ICAM-
1 inhibits the transmission of IL-15-specific signals by impairing IL-15 transpresentation.  
Coupled with the lack of IL-15-driven BrdU incorporation in memory CD8 T cells in the 
absence of ICAM-1, these findings demonstrate a crucial and previously unappreciated role for 
ICAM-1 in IL-15 transpresentation responses.   
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Figure 8.  BMDCs need β2m expression to drive proliferation of memory-phenotype CD8 
T cells.   
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Figure 8.  BMDCs need β2m expression to drive proliferation of memory-phenotype CD8 
T cells.  A) BMDCs were activated at d7 of culture with 150 µg/ml poly I:C for 12-16 hours.  
CD8 T cells were enriched from Wt mice and cultured with BMDCs after poly I:C stimulation 
for 3 days in the presence of BrdU.  Plots are gated on TCRβ+ CD8α+ CD45.1+ cells and 
measure the incorporation of BrdU on CD44 hi CD8 T cells.  Plots are representatives of 
triplicate cultures and two independent experiments.   
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Figure 9. STAT5 phosphorylation in CD8 T cells induced by BMDCs requires IL-
15Rα and ICAM-1 expression by DCs.    
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Figure 9. STAT5 phosphorylation in CD8 T cells induced by BMDCs requires IL-
15Rα and ICAM-1 expression by DCs.  A) Dot plots show phophorylated STAT5 versus 
CD44 expression after gating on CD8α+ TCRβ+ CD45.1+ cells in the cultures indicated.  B) 
Graph shows the average frequency of memory (CD44hi) or naïve (CD44lo) CD8 T cells 
expressing phospho-STAT5 after coculturing with the indicated BMDCs.  In panels A and B, 
error bars represent SD of 3 replicates per group. Experiment shown is representative of three 
experiments performed.  
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4.2.2  ICAM-1 and LFA-1 are important for memory CD8 T cell homeostatic proliferation 
and maintenance 
 
Having demonstrated that ICAM-1 is important for IL-15 transpresentation in a closed system, 
we wanted to examine IL-15 transpresentation responses in vivo.  Homeostatic proliferation of 
memory CD8 T cells is a well-established readout of IL-15 transpresentation so we 
endeavored to analyze the role of ICAM-1 in this response.  Since ICAM-1/LFA-1 interactions 
have multiple functions on T cells that can impact the differentiation and behavior of memory 
CD8 T cells, we chose to examine memory CD8 T cells generated in a normal environment.  
To this end, CD8 T cells were enriched from Wt mice infected at least 50 days earlier with 
VSV, CFSE-labeled, and transferred into either ICAM-1-/- or Wt recipients.  Approximately 30 
days post-transfer, homeostatic proliferation and the total number of the donor VSV-specific 
and memory phenotype CD8 T cells were analyzed.  Among the donor memory phenotype 
CD8 T cells, CFSE dilution was less in ICAM-1-/- mice than in Wt mice in both spleen and BM 
(Figure10A).  Unfortunately, the low number of donor VSV-specific memory CD8 T cells made 
it difficult to clearly assess differences in their level of proliferation (data not shown); however, 
the frequency and total number of VSV-specific CD8 T cells was decreased in ICAM-1-/- mice 
(Figure 10B), suggesting that homeostasis and/or survival of these CD8 T cells was impaired 
in the absence of ICAM-1.  Alternatively, the homeostatic proliferation of antigen-specific OT-I 
memory CD8 T cells was examined.  After memory OT-I T cells were generated in vivo 
following VSV-OVA infection, CD8 T cells were again CFSE-labeled and transferred into 
ICAM-1-/- and WT mice.  Within the ICAM-1-/- mice, the memory OT-I T cells exhibited a 
consistent reduction in cell division compared to OT-I T cells in Wt mice in all tissues (Figure 
10C, D).  Reduced division in ICAM-1-/- hosts was observed in both central and effector 
memory subsets (data not shown).  Similar to that observed with VSV-specific memory CD8 T 
cells, ICAM-1-/- hosts had fewer numbers of donor memory OT-I T cells in each tissue  
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Figure 10.  Homeostatic proliferation of memory CD8 T cells is impaired in ICAM-1-/- 
hosts.    
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Figure 10.  Homeostatic proliferation of memory CD8 T cells is impaired in ICAM-1-/- 
hosts.  A) CD8 T cells were enriched from mice infected at least 60 day previous, CFSE-
labeled and transferred into Wt and ICAM-1-/- mice for 29 days.  Histograms show CFSE 
dilution of CD8+ CD45.1+ CD44hi CFSE+ cells in spleen (SP) and bone marrow (BM).  The 
black underlay represents undivided naïve CD8 T cells.  Gating represents the frequency of 
cells that have not divided.  Plots are representative of 2 mice per group.  B) Histograms 
showing the absolute numbers of N-tetramer specific CD8 T cells after adoptive transfer into 
Wt and ICAM-1-/- hosts.  Error bars represent S.D. of 2 mice per group.  C) CD45.1+ OT-I 
memory CD8 T cells were CFSE labeled and adoptively transferred into CD45.2+ mice for 21 
days. Histograms show CFSE dilution of OT-I cells in SP, BM, and Lung (LG). Gate indicates 
the frequency of cells that have not divided.  The black underlay marks undivided donor CD8 T 
cells.  Plots are representative of 3-4 mice per group.  D) Graphs represent the frequency of 
cells gated as above that failed to divide.  Error bars represent S.D of 3 mice per group.  E)  
Total numbers of OT-I+ memory CD8 T cells in the indicated tissues 21 days post-transfer.  
Error bars represent S.D. of 3 mice per group.  
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compared to WT hosts, implying survival of the memory CD8 T cells is also compromised 
(Figure 10E).  To address whether decreased numbers in the BM and lung were due in part to 
defects in migration, donor cell numbers were also examined 24 hours after transfer before 
effects on homeostasis could occur and no defects in migration to lung or BM were observed 
(data not shown).  By virtue of homeostatic proliferation being exclusively driven by IL-15, we 
conclude from these data that IL-15 transpresentation is indeed impaired in the absence of 
ICAM-1, which is in agreement with our in vitro data.    
 
The absence of ICAM-1 did not completely inhibit the homeostatic proliferation of memory 
CD8 T cells as we had anticipated.  However, since LFA-1 on CD8 T cells can interact with 
other ICAMs, we next wanted to determine if the absence of LFA-1 on the CD8 T cells would 
alter their ability to undergo homeostatic proliferation.  We enriched CD8 T cells from 
unmanipulated CD11a-deficient mice, which we then labeled with CFSE and transferred into 
Wt mice.  2-3 weeks after transfer, we again looked in the spleen and BM to determine the 
extent of homeostatic proliferation the transferred cells had undergone.  As we had 
anticipated, ~80% of memory-phenotype CD8 T cells lacking CD11a failed to undergo 
homeostatic proliferation, in contrast to Wt memory-phenotype CD8 T cells which had 
undergone several rounds of division (Figure 11).  These data and the adoptive transfers into 
ICAM-1-/- mice raise the possibility that other adhesion molecules in addition to ICAM-1 are 
involved in IL-15 transpresentation; LFA-1 expression, however, is essential on CD8 T cells.    
 
4.2.3  Endogenous immune responses in ICAM-1-/- mice are normal 
 
IL-15Rα-/- mice develop lower levels of CD8 T cell memory than WT counterparts in response 
to VSV and indeed a similar phenomenon has been observed using adoptively transferred OT-
I T cells into ICAM-1-deficient mice (7).  We sought to recapitulate these findings by infecting  
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Figure 11.  Homeostatic proliferation of CD11a-/- memory CD8 T cells is impaired.    
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Figure 11.  Homeostatic proliferation of CD11a-/- memory CD8 T cells is impaired.  CD8 T 
cells were enriched from the spleens of unmanipulated Wt and CD11a-‘- mice.  Histograms are 
gated on CD45.2+ CD44hi CD8 T cells.  Interval gate measures the frequency of cells that 
have failed to proliferate after an 18 day transfer period.  Plots are representative of 3 mice per 
group.  
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ICAM-1-/- mice and analyzing the development of endogenous VSV-specific CD8 T cell 
memory but also extended our study to analyze the CD8 T cell memory maintenance.  CD8 T 
cells express ICAM-1 and while the role of ICAM-1 on CD8 T cells is likely for adhesion, ICAM-
1 indeed has a well-established role in antigen presentation which is presumably compromised 
in this model.  Despite this caveat, we investigated whether VSV-specific CD8 T cells 
generated in ICAM-1-/- mice display defective memory CD8 T cell homeostasis.  Surprisingly, 
we found that the expansion, contraction, and memory maintenance of endogenous CD8 T 
cells in ICAM-1-/- mice appeared normal in response to VSV infection (Figure 12A,B). At all 
time points measured, the level of antigen-specific CD8 T cells was not significantly different 
between Wt and ICAM-1-/- mice.  In addition, BrdU incorporation in memory CD8 T cells in 
ICAM-1-/- mice over a two week period was not defective  and actually was increased 
somewhat compared to normal mice, regardless of tissue localization (Figure 12B and data 
not shown).  We next tested the ability of ICAM-1-/- memory CD8 T cells to produce IFN-γ after 
stimulation with peptide.  Previous studies indicated that IFN-γ production by memory CD8 T 
cells generated in ICAM-1-/- mice is defective so we wanted to determine if this was the case in 
our model as well.  Using a peptide encoding for the immunodominant epitope of the VSV N-
protein, we show that in contrast to previous studies, ICAM-1-/- memory CD8 T cells produced 
IFN-γ at equivalent or slightly better levels than Wt memory cells (Figure 12C,D).  Taken 
together, endogenous antigen-specific memory CD8 T cells generated in ICAM-1-/- mice 
display no defects that we could determine and may even perform slightly better than their Wt 
equivalents. 
   
4.2.4  IL-15 expression is elevated in ICAM-1-/- mice 
 
As endogenously-generated ICAM-1-/- memory CD8 T cells are able to respond to IL-15-driven 
phenomena equivalent to their Wt counterparts, we wanted to determine if levels of IL-15 
protein expression were different in these mice.  We reasoned that if IL-15 expression was  
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Figure 12.  Endogenous immune responses to VSV in ICAM-1-/- mice are normal.    
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Figure 12.  Endogenous immune responses to VSV in ICAM-1-/- mice are normal.  A)  Wt 
and ICAM-1-/- mouse were infected with 1x105 pfu VSV.  The frequency of antigen-specific 
CD8 T cells were measured in peripheral blood using a tetramer reagent.  Error bars represent 
standard deviation of 4-5 mice per group.  Plot is representative of 3 independent experiments.  
B)  Upper panel: the frequency of antigen-specific CD8 T cells in the spleen 4 months after 
infection.  Lower panel: mice were fed 0.8 mg/ml BrdU in their drinking water for a two-week 
period, after which time mice were sacrificed and incorporation of BrdU assessed.  Plots are 
representative of 4-5 mice per group and 2-3 independent experiments.  C)  3x106 
Splenocytes from various VSV-immunized Wt and ICAM-1-/- were incubated for five hours with 
a peptide encoding for the antigenic sequence of the VSV N protein in the presence of Golgi 
stop.  Plots are gated on CD44hi CD8 T cells and the frequency of cells producing IFN-γ is 
measured.  Plots are representative of 3 mice per group.  D)  The enumeration of IFN-γ-
producing CD44hi CD8 T cells.  Error bars are standard deviation of 3 mice per group.   
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increased in ICAM-1-/- mice, this could explain how less-efficient IL-15 transpresentation could 
still generate normal responses in memory CD8 T cells.  We analyzed splenic DCs from Wt, 
IL-15-/-, RAG-1-/- (positive control; more on this in chapter 5), and ICAM-1-/- mice for IL-15 
expression directly ex vivo.  As we had anticipated, IL-15 expression was indeed increased on  
DCs from ICAM-1-/- mice (Figure 13 A,D), albeit not to the same extent as in RAG-1-/- mice.  
These data raise the possibility that memory CD8 T cells generated in an ICAM-1-/- 
environment have more IL-15 available to them, which could explain why homeostatic 
proliferation and memory generation are not affected after virus infection in ICAM-1-/- mice. 
 
4.2.5  ICAM-1 is not required for IL-15 transpresentation in acute models of 
homeostatic proliferation 
 
Our initial findings linking ICAM-1 to transpresentation phenomena utilized models of CD8 T 
cell proliferation so we next wanted to determine if the main role for ICAM-1 in IL-15 
transpresentation is to drive the proliferation of memory CD8 T cells.  We used a model which 
was originally described as bystander proliferation, so-called because mice were treated with 
poly I:C, which induces IL-15 expression, and subsequently memory CD8 T cells proliferated.  
The proliferation required IL-15Rα expressed by host cells and as such this model can be 
used as another model of transpresentation.  We enriched CD8 T cells from congenically-
marker Wt mice, CFSE-labeled the cells and transferred them into Wt and ICAM-1-/- mice.  
One day later, we treated the mice with 150 µg poly I:C and then analyzed the dilution of 
CFSE after 5 days.  Previous studies used IL-15Rα-/- deficient hosts to analyze the role of IL-
15Rα in driving the proliferation (38); we however are using ICAM-1-/- hosts to determine if 
ICAM-1 expression affects the ability of memory CD8 T cells to respond to elevated levels of 
IL-15.  We measured the frequency of cells in the spleen and bone marrow that had not 
divided, those that had divided between 2 and 5 times, as well as the cells that had divided so  
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Figure 13.  IL-15 expression on DCs is increased in ICAM-1-/- mice.    
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Figure 13.  IL-15 expression on DCs is increased in ICAM-1-/- mice.  A)  Comparison of IL-
15 expression among various mice.  Flow cytometry plot showing the level of IL-15 staining (y-
axis) on splenic DCs from Wt, IL-15-‘-, RAG-1-/-, and ICAM-1-/-.  As indicated on the x-axis, 
each population shows representative staining of IL-15 from each mouse.  Each population is 
representative of three mice per group and two independent experiments.  B)  Histogram 
shows the geometric mean of fluorescence intensity (MFI) on splenic DCs from the indicated 
mice.  Error bars represent the standard deviation of three mice per group.  The asterisk 
denotes an MFI that is statistically significant from IL-15-/- DCs (p<.05).    
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Figure 14.  Proliferation of memory CD8 T cells after up-regulating IL-15 expression by 
poly I:C is normal.    
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Figure 14.  Proliferation of memory CD8 T cells after up-regulating IL-15 expression by 
poly I:C is normal.  A)  CD8 T cells were enriched from unmanipulated Wt mice, CFSE-
labeled and transferred into Wt or ICAM-1-/- mice.  One day later, the recipient mice were 
injected with 150 µg poly I:C intraperitoneally to induce IL-15 expression.  Five days after poly 
I:C treatment, mice were sacrificed and proliferation assessed in the spleen and bone marrow.  
Plots are gated on CD45.1+ CD44 hi CD8 T cells.  Interval gates measure the frequency of 
donor cells that have failed to divide, those that have divided 1-6 times, and those that have 
divided enough times to dilute their CFSE to undetectable levels.  Plots are representative of 3 
mice per group from 2 independent experiments.  
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many times their CFSE was completely diluted.  In Wt and ICAM-1-/-, there was no difference 
in any of these demarcations of division (Figure 14), suggesting that ICAM-1 does not play a 
role in poly I:C-induced IL-15 transpresentation.  Previously we had observed that ICAM-1-/- 
were deficient in their ability to induce the homeostatic proliferation of  
transferred memory CD8 T cells; however in this model of more acute proliferation, ICAM-1-/- 
were equivalent to Wt mice in their ability to drive proliferation.   
 
Another model of IL-15 driven proliferation involves the use of lymphopenic mice as hosts for 
adoptively transferred CD8 T cells.  In a phenomenon referred to as lymphopenia-induced 
proliferation (LIP), T cells transferred into lymphopenic hosts respond to the homeostatic 
cytokines IL-15 and IL-7 that are more accessible when there are no other T cells with which 
to compete (75).  This response involves the activation of naïve CD8 T cells by IL-7 and TCR 
stimulation, followed by IL-15-induced proliferation of memory-phenotype CD8 T 
cells(6,76,77).  As our interest is in IL-15 and not IL-7, our experiments were conducted in the 
presence of a blocking antibody against IL-7Rα so that the transferred cells cannot respond to 
IL-7.  We crossed RAG-1-/- mice with ICAM-1-/- and IL-15Rα-/- mice to establish two 
environments where IL-15 is more available but 1) cell adhesion is compromised or 2) IL-15 
cannot be presented , respectively.   
 
We generated memory CD8 T cells as before using VSV, enriched CD8 T cells from immune 
mice, CFSE-labeled the cells and transferred into the various mice: RAG-1-/-, RAG-1-/- x ICAM-
1-/-, and RAG-1-/- x IL-15Rα-/-.  Before transfer, anti-IL-7Rα was added to the CD8 T cells, and 
the recipient mice received 0.5 mg of anti-IL-7Rα prior to transfer as well.  After 5 days we 
assessed proliferation in the spleen and bone marrow on antigen-specific as well as memory-
phenotype CD8 T cells.  Proliferation of antigen-specific memory CD8 T cells in both tissues 
was not very robust but the frequency of cells that did not divide was equivalent among RAG- 
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1-/- and RAG-1-/- x ICAM-1-/- mice (35%) (Figure 15A), indicating that LIP is not compromised in 
the absence of ICAM-1.  RAG-1-/- x IL-15Rα-/- recipients, on the other hand, failed to support 
normal amounts of proliferation (60% undivided, Figure 14A), in keeping with our expectation 
that the increased availability of IL-15 would be functionless without IL-15Rα to deliver it. 
Proliferation among memory-phenotype CD8 T cells was far more robust, with the majority of 
the population undergoing at least two rounds of division (Figure 14 B,C).  Due to the 
extensive proliferation characteristic of this model, we were able to measure the frequency of 
memory-phenotype CD8 T cells within several generations.  Once again, both RAG-1-/- and 
RAG-1-/- x ICAM-1-/- mice drove equivalent amounts of proliferation as evidenced by the similar 
frequencies of memory-phenotype CD8 T cells within each generation (Figure 14B,C).  RAG-1-
/- x IL-15Rα-/- mice again displayed defective proliferation, with the vast majority of memory 
cells remained in the parent generation (Figure 14 B,C).  Based on these two models of acute 
IL-15-driven proliferation as well as homeostatic proliferation, the role of ICAM-1 in IL-15 
transpresentation to memory CD8 T cells seems to be important mainly in situations where IL-
15 expression is low.  Where IL-15 is more highly expressed or more available, however, 
ICAM-1 does not appear to be important in IL-15 transpresentation.     
 
4.3   Discussion 
Previous studies of memory CD8 T cell homeostasis and maintenance have clearly 
established the role of IL-15 transpresentation in these processes but our understanding of 
how the interaction between transpresenter and responder occurred remained unclear. As 
such, we sought to explain how IL-15 transpresentation occurs by addressing the role that 
specific adhesion molecules have in enabling transpresentation to memory CD8 T cells. Our 
finding that ICAM-1/LFA-1 is important in enabling IL-15 transpresentation is the first study to 
link adhesion molecules with IL-15 transpresentation.  The involvement of adhesion molecules 
in IL-15 transpresentation spans a crucial gap in our understanding of this process and may   
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Figure 15.  Lymphopenia-induced proliferation does not require ICAM-1 expression.    
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Figure 15.  Lymphopenia-induced proliferation does not require ICAM-1 expression.  A)  
CD8 T cells were enriched from VSV-immunized mice, CFSE-labeled and transferred into 
RAG-1-/-, RAG-1-/- x ICAM-1-/-, and RAG-1-/- x IL-15Rα-/- mice in the presence of CD127 
blocking Ab.  Plots are gated on TCRβ+ CD8α+ CD44 hi N-tetramer-specific T cells from the 
spleen and bone marrow 5 days post-transfer.  Interval gate measures the frequency of cells 
that have not divided.  Plots are representative of 3 mice per group.  B, C)  Histograms 
showing the frequency of memory-phenotype CD8 T cells that have divided the indicated 
number  of times in the various host mice in the spleen (B) and BM (C).  Error bars are 
standard deviation of three mice per group.  Data is representative of two independent 
experiments.   
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serve as the basis for furthering our understanding of how the specificity observed in IL-15 
transpresentation is achieved.  For example, the inability of a given cell to respond to or 
transpresent IL-15 may be related to its lack of appropriate adhesion factors and as such could 
be a mechanism that has developed to control IL-15 responses. The recent discoveries 
identifying the cells that transpresent IL-15 to CD8 T cells as well as NK/NKT cells and 
intestinal intraepithelial lymphocytes has now given us a platform upon which to begin 
elucidating factors which enable a particular cell type to transpresent IL-15 (62,72,78,79).  The 
present study therefore represents a potential new avenue for understanding the 
characteristics that enable cells to respond to transpresented IL-15 and could lead to the 
design of strategies to heighten the efficacy and specificity of therapies that seek to generate 
IL-15 responses.  Additionally, as ICAM-1 interacts with LFA-1, modulating the affinity of LFA-
1 could be used to enhance IL-15 signals in ex vivo stimulation of T cells for the preparation of 
therapeutic adoptive T cell transfers.   
 
The decreased level of homeostatic proliferation observed in adoptive transfers into ICAM-1-/- 
mice was not as striking as that which has been described in IL-15Rα-/- mice, where 
homeostatic proliferation is almost completely compromised (22,24).  This result suggests that 
ICAM-1 is not absolutely necessary for IL-15 transpresentation and may function mainly to 
enhance transpresentation.  Alternatively, cell adhesion may be integral for IL-15 
transpresentation but mediated by multiple adhesion molecules simultaneously.  For example, 
in addition to acting as the ligand for ICAM-1, LFA-1 can also bind with ICAM-2 and ICAM-3.  
Furthermore, while DCs are a major cell type transpresenting IL-15 to memory CD8 T cells 
(58,72), other cells types such as macrophages and BM stromal cells may utilize other 
adhesion molecules to facilitate IL-15 transpresentation.  As memory CD8 T cells in the lung 
are less dependent on IL-15 transpresented by hematopoietic cells (41) and DCs are rare in 
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the BM, our data showing the importance of ICAM-1 in the spleen could reflect a specific role 
for ICAM-1 between memory CD8 T cells and DCs.   
 
Because ICAM-1/LFA-1 is involved in T cell activation (50,52) and utilized during the 
contraction (7,53), memory CD8 T cells generated in the absence of ICAM-1 may have an 
altered ability to undergo homeostasis that is unrelated to the role of ICAM-1 in IL-15 
transpresentation.  Indeed, it has been reported that the absence of ICAM-1 by APCs during 
priming promotes the differentiation of effector memory over central memory (52).  In addition, 
Chang et al (80) showed that the asymmetric partitioning of IL-7Rα, an important fate 
determinant (14), is lost upon cell division in the absence of ICAM-1.   
 
The elevated level of IL-15 expression in ICAM-1-/- mice is a truly intriguing finding due to the 
differential effects on memory CD8 T cells we observe when memory is generated in Wt mice 
versus when memory is generated in ICAM-1-/- mice.  Memory CD8 T cells generated in Wt 
mice and transferred into ICAM-1-/- mice proliferate less and have reduced survival, whereas 
both phenomena are unaffected with endogenously-generated ICAM-1-/- memory.  One 
potential explanation for this is that memory generated in the different hosts is programmed 
differently, such that requirements for IL-15 and transpresentation are altered by virtue of the 
environment in which the memory CD8 T cells are raised.  Our data showing that memory 
CD8 T cells respond normally to elevated levels of IL-15 after in vivo poly I:C treatment (Figure 
14) and in lymphopenia-induced proliferation (Figure 15) suggest though that memory CD8 T 
cells generated in ICAM-1-/- mice may be inherently different from those generated in Wt mice.  
Whether or not this difference is cell intrinsic or –extrinsic – indeed, even what the nature of 
this alteration could be – remains subject to speculation.  Since our results do not mirror 
previous findings using different model systems, we suspect that compensatory mechanisms 
exist that may mask the functions of ICAM-1, which are dependent on the type of pathogen, 
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strength of stimulation and/or inflammatory milieu.  Taken together, these issues confound the 
study of homeostasis of endogenous memory CD8 T cells generated in ICAM-1-/- mice as one 
cannot exclude the possibility that the absence of ICAM-1 alters the programming of memory 
CD8 T cells or generates a population that has adapted to an ICAM-1-/- environment. 
 
Our data showing an absolute requirement for ICAM-1 in IL-15 transpresentation in vitro is in 
contrast to the partial requirement observed in vivo and could reflect a requirement that is 
specific for DCs.  Alternatively, these cultures measure acute responses that are different from 
the much slower homeostatic proliferation occurring in vivo (81).  Therefore, cumulative IL-15 
signals, occurring inefficiently over time and by different cell types, may obscure the in vivo 
role of ICAM-1 in IL-15 transpresentation.  Another interesting feature of this coculture system 
is the requirement for MHC class I on BMDCs.  Whether the proliferation seen by memory-
phenotype CD8 T cells is in response to auto antigens presented by the DCs remains to be 
determined.  IL-15 can potentiate CD8 T cell responsiveness to weak TCR stimulation (82), 
which could be an explanation for why MHC class I is involved.  This feature of IL-15 may be 
especially relevant when seeking to engender an immune response against self antigens.  It 
will be interesting to determine if antigen-specific memory CD8 T cells proliferate in this 
system as well.  If antigen-specific memory CD8 T cells fail to proliferate as well, that will 
demonstrate that this response is not simply the proliferation of autoreactive CD8 T cells.  
Antigen-specific memory CD8 T cells can proliferate robustly in MHC class I-deficient hosts in 
response to IL-15/IL-15Rα complexes (83) so this will be a good litmus test to determine if 
ICAM-1 truly is essential for IL-15 transpresentation in our model.  
 
Other factors such as various TNFR family members, i.e. CD27, 4-1BB among others, are 
reported to influence memory CD8 T cells as well (84-86).  4-1BB is a particularly interesting 
member of this family in that it has been linked specifically with the homeostatsis of memory 
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CD8 T cells.  4-1BB is mainly expressed on CD8 T cells that have recently been activated by 
TCR stimulation (87) but its expression can also be modulated by IL-15 stimulation (85,86).  
Two studies have linked signals derived from 4-1BB stimulation with the survival and/or 
proliferation of memory CD8 T cells.  Although we did not test this, memory CD8 T cells 
generated in ICAM-1-/- mice may have altered expression or responsiveness through 4-1BB 
that could contribute to lack of effect we saw in that particular model.  Aside from that 
possibility, through lasting contact mediated by ICAM-1/LFA-1, it is possible that simultaneous 
or sequential signals are delivered via these TNFR family members to the T cells and could 
help explain some inconsistencies that have been seen regarding the roles of these molecules 
(86).  It will be interesting for future studies to explore the relationship between ICAM-1/LFA-1 
and how these molecules might interact alongside IL-15. 
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Chapter 5– IL-15 expression 
 
5.1   Introduction 
The functions of IL-15 serve to maintain homeostasis, which necessarily requires tight 
regulation of IL-15 so that the balance of homeostasis isn’t disturbed.  IL-15 potently 
stimulates CD8 T cells (among others) when it is in excess, which has been determined using 
transgenic mouse models (88,89).  Consequently, the regulation of IL-15 expression is crucial 
to maintaining homeostasis.  As discussed in section 1.4, many layers of regulation exist to 
control IL-15 levels.  Likely as a consequence of the various levels of regulation, very little is 
known about steady-state IL-15 expression because it is presumably quite low – potentially 
undetectable.  Furthermore, even under stimulatory conditions, reports of IL-15 protein 
expression are sparse.  While IL-15 mRNA expression has long served as the benchmark for 
our understanding of IL-15 expression, there exists a substantial bridge to cross before IL-15 
mRNA becomes a mature, bioactive protein.   
Because of the importance of IL-15 in generating and maintaining memory CD8 T cells, an 
undertaking to study and characterize IL-15 protein expression – both steady-state and 
induced – is crucial as this will better enable the rational design of therapies or vaccines.  
Reconciling IL-15 mRNA expression data with protein expression will perhaps elucidate 
mechanisms behind the efficacy of certain therapeutic interventions over others and may 
uncover further unappreciated applications for these therapies. 
 
5.2  Results 
 
5.2.1  IL-15 Expression in vitro 
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Previous attempts in our lab to measure cell-surface IL-15 expression using a flow cytometry-
based detection method had been unsuccessful using all of the available IL-15 antibodies 
(data not shown).  However, two published reports demonstrating IL-15 staining (46,90) using 
an antibody that had recently become available prompted us to deploy this reagent in our 
assays as well.  As shown in Figure 2E, after overnight activation of bulk splenocytes from Wt 
and IL-15-/- mice with LPS, we could successfully measure IL-15 protein expression on DCs 
(58).  An intriguing aspect of this experiment was that even when splenocytes were not 
stimulated – just incubated in media – we could detect IL-15 expression on DCs in these 
cultures as well (Figure 2E) (58).  Prompted by these data, we measured IL-15 protein 
expression on other spleen and bone marrow cell populations after overnight culture.  Among 
spleen populations, we observed IL-15 staining on eosinophils in addition to DCs (Figure 16A), 
but not on neutrophils or pDCs (data not shown).  In the BM, neutrophils, eosinophils and 
macrophages all expressed IL-15 after overnight culture (Figure 16B).  Additionally, we 
cultured cells from the SP and BM with LPS and IFN-α to correlate IL-15 protein expression 
levels with previous studies that observed increases in IL-15 mRNA expression after culturing 
with these stimuli.  Interestingly, the expression of IL-15 after culture did not change radically 
with LPS and IFN-α treatment: eosinophils in the spleen as well as BM macrophages 
displayed the greatest sensitivity to these stimuli whereas DCs and neutrophils were less 
affected (Figure 16A,B).  We also incubated splenocytes from IL-15-/- and IL-15Rα-/- mice 
overnight with or without LPS to verify that the IL-15 staining was associated with IL-15Rα.  
Indeed, IL-15 expression was absent on DCs from both types of splenocytes (Figure 16C), 
indicating that the IL-15 we are detecting is at the cell surface and requires IL-15Rα 
expression.   
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Figure 16.  Expression of IL-15 protein is detectable after overnight culture and with 
various stimuli.    
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Figure 16.  Expression of IL-15 protein is detectable after overnight culture and with 
various stimuli.  A,B)  1x107 cells from the spleen (A) and BM (B) of Wt and IL-15-/- mice 
were incubated overnight in the absence or presence of 1 µg/ml LPS or 300 U/ml IFN-α.  
Filled histograms represent background staining of IL-15 on IL-15-/- cells; open histograms are 
IL-15 staining on Wt cells.  Plots are representative of 2-3 experiments.  C)  1x107 splenocytes 
from IL-15-/- and IL-15Rα-/- were incubated overnight in the presence or absence of LPS as 
before.  Filled histograms represent IL-15 staining on IL-15-/- cells and open histograms 
represent staining on IL-15Rα-/- cells.       
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5.2.2  Steady-state IL-15 expression 
 
Given the success of this particular antibody to detect transpresented IL-15 in vitro, we then 
sought to measure IL-15 expression directly ex vivo on various hematopoietic cell types.  From 
our studies as well as others, we know – albeit indirectly – that DCs make IL-15; however, 
other cells must make IL-15 as well because IL-15 expression by DCs alone is not sufficient to 
drive all aspects of IL-15 biology.  Measuring IL-15 expression directly ex vivo is also more 
informative than after culture because memory maintenance occurs in the absence of overt 
stimulation, implying that IL-15 is expressed at some level under steady-state conditions.  As 
the spleen and bone marrow are major sites of homeostatic proliferation, we identified several 
hematopoietic lineages that reside in these tissues and measured the expression of IL-15 on 
the cell surface.  Curiously, in neither tissue we were able to detect IL-15 expression directly 
ex vivo on any of the various cell types identified (Figure 17A,B,C).  Some of these 
populations, such as eosinophils, neutrophils and basophils, have never been linked with roles 
in IL-15 biology and the lack of IL-15 expression is therefore not surprising.  More interesting is 
that monocytes and DCs – two cell types heavily linked with IL-15 expression – were negative 
as well (Figure 17A,B).  While the former observation could be expected, the latter observation 
was more startling as we and others have shown that these cells do indeed make and 
transpresent IL-15, but these data suggest that either the expression is too low to detect by 
flow cytometry, or these cells do not make IL-15 under steady-state conditions.  CD8 and CD4 
T cells, B cells and NK cells also did not express IL-15 (Figure 17C).   
 
While levels of IL-15 mRNA have been measured in monocytes and DCs (43), a direct 
comparison of IL-15 mRNA between different hematopoietic lineages has never been 
analyzed.  Our first approach to measure IL-15 protein expression by flow cytometry could not  
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 Figure 17.  Steady-state expression of IL-15 is undetectable in Wt mice.    
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Figure 17.  Steady-state expression of IL-15 is undetectable in Wt mice.  A)  IL-15 
expression on granulocyte populations in the bone marrow and spleen directly ex vivo.  B)  IL-
15 expression on splenic DC populations directly ex vivo.  Data are representative of at least 
four independent experiments (A, B).  C)  IL-15 expression on lymphocytes.  Filled histograms 
represent IL-15-/- staining, open histograms represent Wt staining.  Data are representative of 
two independent experiments. 
  
84 
 
detect any cytokine: in lieu of this, we turned to qtPCR to measure mRNA levels.  As 
previously mentioned, mRNA levels are informative but certainly do not always mean the  
mature protein is produced, regardless of expression levels.  Nevertheless, we sorted cell 
types from the spleen and bone marrow according to the gating strategy in Figure 18 and 
isolated RNA.  After cDNA synthesis, we performed qtPCR to measure the amount of IL-15 
mRNA expression among these cell types.  A cursory analysis of the mRNA expression 
reveals that most of the cell types we sorted do contain some level of IL-15 mRNA, with the 
exception of pDCs (Figure 19A,B).  The truly perplexing observation is that basophils and 
neutrophils in the spleen and BM and BM mast cells produce the highest levels of IL-15 
mRNA, (Figure 19A,B) yet, as mentioned before, these cells have never been considered to 
have a role in IL-15 transpresentation.  Monocytes, cDCs, and CD8α+ DCs, on the other hand, 
express relatively low levels of IL-15 mRNA (Figure A,B).  Again, these data are rather 
shocking in that the cells that actually transpresent IL-15 express very little of its mRNA.  
Collectively, however, these data tell us that IL-15 mRNA levels do not strictly correlate with 
protein expression, or indeed transpresentation ability.   
 
5.2.3  IL-15 expression is increased in RAG-1-/- mice 
 
The lack of IL-15 expression on DCs under homeostatic conditions coupled with the apparent 
IL-15 expression after culture led us to hypothesize that the DCs were receiving a signal in 
culture that causes them to produce IL-15.  We began to question the role of T cells in IL-15 
expression in vivo.  Some evidence exists that CD8 T cells may be “sinks” for IL-15 and, 
consequently, in a CD8 T cell-replete mouse, the IL-15 that is produced may be used up by 
CD8 T cells (91).  Alternatively, CD8 T cells may provide a negative feedback signal to DCs to 
stifle IL-15 expression so that it isn’t expressed inappropriately.  To test if T cells in general 
influence IL-15 expression, we isolated cells from the spleen and BM from Wt and RAG-1-/-  
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 Figure 18.  Gating strategy and markers used to identify various myeloid cell 
populations for cell sorting.    
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Figure 18.  Gating strategy and markers used to identify various myeloid cell 
populations for cell sorting.  All plots are gated on B220-, TCRβ- cells in the spleen.  A) 
cDC: CD11c hi, CD11b+; CD8 DC: CD11c hi, CD11b-; pDC: CD11c int, CD11b-, Ly6C+.  B) 
Mature neutrophil: CD11b+, Gr1 hi, SSC int; monocyte: CD11b+, Gr1 int, Ly6C+, SSC lo; 
immature neutrophil: CD11b+, Gr1 int, Ly6C-, SSC lo; eosinophil: CD11b+, Gr1 int, SSC hi; 
basophil: CD11b+, Gr1-, FcεRI+; mast cell: CD11b-, c-kit+.   
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Figure 19.  IL-15 mRNA is widely expressed among different BM-derived cell types.    
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Figure 19.  IL-15 mRNA is widely expressed among different BM-derived cell types.  A,B)  
qtPCR was done to determine the amount of IL-15 message in various sorted myeloid cell 
populations from the spleen (A) and BM (B).  Histograms represent IL-15 expression relative 
to β-actin as determined by calculating average ∆CT values of triplicate assays for each cell 
population.  Data are representative of two independent experiments (both sorting of cells and 
qtPCR).  Error bars are derived from the standard deviation in ∆CT values. 
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mice and stained them directly ex vivo for IL-15 expression.  To our surprise, we saw that in 
RAG-1-/- mice, both cDCs and CD8α+ DCs in the spleen express cell surface IL-15, evidenced 
both by the flow plots and by measuring the MFI of IL-15 expression (Figure 20A,B).  
Additionally, IL-15 was also detected on BM eosinophils, monocytes and neutrophils (Figure 
20C).  These data are the first to demonstrate IL-15 staining that did not involve exogenous 
stimulation, and also to demonstrate that IL-15 is expressed by more cells than would be 
anticipated.  Having already observed that IL-15 protein expression is increased on DCs in 
RAG-1-/- mice, we measured IL-15 mRNA expression to determine if different levels of IL-15 
transcript are the cause of the increase in protein expression.  We sorted DCs and neutrophils 
from the spleen as before and used qtPCR to measure IL-15 transcripts.  In both populations, 
IL-15 mRNA expression was not significantly different (Figure 20D), meaning the different 
amounts of IL-15 found on the cell surface was not related to differential transcription. 
 
5.2.4  Total body irradiation results in increased IL-15 expression 
 
We hypothesized that it was the lymphopenic state inherent to RAG-1-/- mice that resulted in 
increased IL-15 expression and next sought to analyze another model of lymphopenia that is 
commonly used: total body irradiation.  Total body irradiation is typically used to ablate 
lymphocytes prior to BM transplantation to ward off potential host versus graft responses, as 
well as to provide a niche into which the new BM can expand.  We used this approach to 
establish lymphopenia in Wt and IL-15-/- mice to determine if IL-15 protein expression is 
increased in this model as well.  Mice were given a sub-lethal dose of total body irradiation 
(700 cGy) to ablate lymphocytes and were analyzed one day later for IL-15 protein expression.  
After irradiation, we saw increases in IL-15 expression on several hematopoietic cells, 
including BM monocytes, neutrophils, and eosinophils, as well as splenic DCs (Figure 21A,B).  
The effect was most pronounced in the BM, with BM monocytes showing the greatest increase 
in protein expression (Figure 21 A,B).  These results indicate that after total body 
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Figure 20.  IL-15 expression is increased in RAG-1-/- mice.    
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Figure 20.  IL-15 expression is increased in RAG-1-/- mice.  A)  DC populations were 
isolated from the spleens of Wt and RAG-1-/- and stained for surface IL-15 expression.  Filled 
histograms represent staining on Wt cells and open histograms represent staining on RAG-1-/- 
cells.  B, C, and D) Bar graphs showing the MFI of IL-15 expression on Wt and RAG-1-/- cell 
populations from the indicated tissue.  Cell populations in (B) are from the spleen.  Results are 
representative of 3-4 experiments and 2-5 mice per group.  E) Sorted splenic DC and 
neutrophil populations were analyzed by qtPCR for expression of IL-15 transcripts.  Results 
are representative of two independent experiments.    
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Figure 21.  Sublethal irradiation induces IL-15 expression.    
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Figure 21.  Sublethal irradiation induces IL-15 expression.  A) Histograms show IL-15 
staining on spleen and bone marrow cell populations one day after receiving a sublethal (700 
cGy) dose of irradiation.  Filled histograms represent background staining on irradiated IL-15-/- 
cells and open histograms represent staining on irradiated Wt cells.  B) Bar graphs showing 
the MFI of IL-15 staining on Wt or irradiated Wt cell populations from the spleen and bone 
marrow.  Error bars represent standard deviation of 2-3 mice per group.   
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irradiation, accompanying the ablation of lymphocytes is an increase in expression of IL-15.  
Whether or not the increase in IL-15 expression on cells such as neutrophils or eosinophils is 
consequential remains to be determined, but certainly an increase in IL-15 on monocytes and 
DCs would be important to consider for their ability to transpresent. 
 
5.3  Discussion 
 
We have now determined that IL-15 expression in Wt mice is too low to detect, or possibly is 
simply not expressed.  We have, however, observed that in lymphopenic conditions, IL-15 is 
increased, not only on DCs but other hematopoietic cell types as well.  While anecdotal 
evidence has identified a role for IL-15 transpresentation by DCs, it had yet to be shown that 
DCs produce cytokine homeostatically, in the absence of overt stimulation.   
 
Our data here are the first to observe that IL-15 expression is increased in lymphopenic 
environments.  Studies of adoptive transfers of CD8 T cells into RAG-1-/- mice have observed 
that the subsequent proliferation undergone by the CD8 T cells is due in part to IL-15, but this 
was explained as the increased availability of cytokine, not an increase in cytokine expression.  
Here, however, we’ve shown that IL-15 expression is indeed increased in lymphopenic 
environments, which leads to some very intriguing possibilities regarding IL-15 regulation.  The 
increased expression of IL-15 by DCs may indicate that the presence of T cells - or CD8 T 
cells in particular – down-regulates IL-15 expression.  The CD8 T cells may “use” all of the IL-
15 as well.  Both of these scenarios would explain why IL-15 is so low as to be undetectable in 
normal mice.  However, another particularly piquant possibility is that the regulation of IL-15 
expression by DCs is not necessarily related to CD8 T cells, but rather CD4 T cells.  It was 
demonstrated that in the absence of CD4+ CD25+ T cells, memory CD8 T cells transferred 
into RAG-1-/- mice proliferated more than when CD4+ CD25+ T cells were present (92).  The 
population of CD4+ CD25+ T cells is known to contain regulatory T cells and it is likely that the 
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presence of Treg cells modulated the proliferation of memory CD8 T cells.  The exact 
mechanism of this suppression was not fully explored, but we posit a situation wherein 
regulatory T cells (Tregs) modulate IL-15 expression on DCs, which in turn modulates the 
degree of proliferation.  In an intact animal, Tregs may regulate the constitutive expression of 
IL-15 and in so doing, limit our ability to detect the cytokine.  Additionally, while Tregs are 
known to modulate the immune system by TGF-β, they also act in cell contact-dependent 
mechanisms as well.  Indeed, our data showing ICAM-1-/- mice have increased IL-15 
expression would agree with this theory.  Because the IL-15 expression is not as high in 
ICAM-1-/- mice as it is in RAG-1-/- mice, if indeed Tregs are involved in regulating IL-15 it is likely 
through mechanisms additional to their contact-dependent suppression mechanisms.  While 
we have yet to definitely determine a role for Tregs in the regulation of memory CD8 T cell 
homeostasis, it remains a highly intriguing possibility.   
 
As we’ve now shown, cells such as eosinophils and neutrophils have the ability to express IL-
15.  These two examples of previously unheralded yet potential sources of IL-15 raise several 
questions in the field of IL-15.  We’ve shown that various CD11b+ CD11c- spleen populations 
express IL-15Rα (Figure 2A)(58), and eosinophils and neutrophils fall into this staining pattern.  
As mentioned previously, another study corroborated our earlier findings regarding DCs 
transpresenting IL-15 to memory CD8 T cells using various Cre-lox mice(72).  One of the 
promoters used to drive Cre recombinase expression was LysM, a promoter used by 
macrophages as well as granulocytes (eosinophils, basophils, neutrophils) (93).  While this 
group reportedly was unable to detect IL-15Rα expression on neutrophils, apparently 
eosinophils were not analyzed.  The working assumption then was that LysM-directed IL-
15Rα deletion affected only macrophages but the possibility exists that eosinophils, and 
potentially neutrophils, were affected in their ability to transpresent IL-15 as well.  
Unfortunately, currently there is no way to specifically deplete eosinophils so it will be difficult 
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to prise apart the role they may have in IL-15 transpresentation from macrophages.  We did 
attempt, however, to study homeostatic proliferation in neutropenic mice, which we established 
by antibody depletion as well as G-CSFR-/- BM chimeras (data not shown) but neither model 
satisfactorily depleted neutrophils.  In these models, in any event, homeostatic proliferation 
was not affected.   
 
Based on our detection of elevated IL-15 expression in RAG-1-/- mice, our interpretation of the 
finding that IL-15 is increased after irradiation is that the lack of T cells influences the level of 
IL-15 expression.  An alternative explanation is an emerging concept that radiation can induce 
IFN-α/β expression, which has been demonstrated to be important for the control of tumor 
growth after radiotherapy (94).  This certainly fits with our data that DCs upregulate IL-15 
expression after stimulation with IFN-α.  It will be interesting to determine which of these 
factors – lymphopenia or IFN-α stimulation – is the true cause of the increase in IL-15 
expression.  Nevertheless, our observation that IL-15 is increased would certainly be of 
interest to the field of tumor biology because IL-15 has been shown to enhance the ability of 
the immune system to control tumor growth (91).  As our approach used total body irradiation, 
the effects are likely too widespread to attribute to any one factor so a more directed delivery 
of radiation would be a superior approach.   
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Chapter 6 – Future Directions and General Discussion  
 
6.1   Summary  
6.1.1  Results of chapter 3 
In aim 1 I sought to determine the role that DCs play in transpresenting IL-15 to memory CD8 
T cells, based on the hypothesis that DCs are the main cell transpresenting IL-15.  DCs are 
mainly known as antigen-presenting cells and despite some evidence that they express IL-15 
transcripts, little was known about whether or not they could indeed transpresent IL-15.  
Therefore, my goal was to describe a new feature of DCs, this one related to their role as 
“cytokine-presenters.”  Using a transgenic model of IL-15Rα expression, I took away the ability 
of all cells in the mouse to transpresent IL-15, excepting DCs.  In this model I observed that 
DCs can very efficiently recover the loss of the CD44 hi memory-phenotype pool of CD8 T 
cells that is found in mice globally lacking IL-15Rα (Figure 3B).  Transpresentation by DCs did 
not recover IL-15-dependent CD8 T cell development in the intestine (Figure 3C), however, 
demonstrating that the delivery of IL-15 is mediated by specific cell types – DCs could not 
substitute for the natural IL-15 source.  In the contraction phase of an antiviral immune 
response, IL-15 transpresentation by DCs enhanced the survival of contracting cells relative to 
IL-15Rα-/- mice (Figure 4A,F), which subsequently enabled the generation of a higher level of 
memory (Figure 4A,  comparing CD11c/IL-15Rα Tg1 and IL-15Rα-/-).  Specifically, DCs 
supported the survival of cells that were KLRG-1+ and CD27-, cells that failed to survive in IL-
15Rα-/- mice.  Exclusive transpresentation by DCs did not fully recoup the survival afforded by 
Wt mice (Figure 4), however, indicating that cells other than DCs transpresent IL-15 to CD8 T 
cells for their survival during the contraction.  I found that the main role for DCs in IL-15 
transpresentation to memory CD8 T cells was for driving homeostatic proliferation, a function 
necessary for the long-term survival of established memory CD8 T cells.   
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6.1.2   Results of chapter 4 
In aim 2, my goal was to determine if there was any relationship between IL-15 
transpresentation and adhesion molecule expression, specifically ICAM-1.  I had hypothesized 
that ICAM-1 expression could be integral to IL-15 transpresentation, or could simply function to 
enhance IL-15 transpresentation.  I found that in an in vitro model of IL-15 transpresentation, 
ICAM-1 expression by BMDCs was essential to drive the proliferation of memory-phenotype 
CD8 T cells.  Somewhat contrastingly, I found that ICAM-1 was not required for in vivo 
homeostatic proliferation of Wt memory CD8 T cells.  In these adoptive transfers, I found that 
CD8 T cells – specifically memory CD8 T cells – did not undergo homeostatic proliferation to 
the same extent in ICAM-1-deficient mice that cells transferred into Wt mice did.  Essentially, 
fewer memory CD8 T cells divided in ICAM-1-/- hosts.  Accompanying this reduced proliferation 
was less survival as evidenced by fewer memory CD8 T cells recovered in ICAM-1-/- mice.  
Further in vivo experiments using similar adoptive transfer methodology but analyzing more 
acute proliferation responses revealed that ICAM-1 expression is not required at all in 
situations where IL-15 expression is elevated.  Specifically, the use of poly I:C to stimulate IL-
15 expression showed no reduction in the proliferation of memory CD8 T cells.  Similarly, 
RAG-1-/- x ICAM-1-/- mice also drove normal levels of proliferation.  To summarize these 
findings, I have determined that ICAM-1 expression is important but not required for IL-15 
transpresentation where normal, homeostatic levels of IL-15 are present.  Where IL-15 
expression is increased, however, ICAM-1 is not involved in IL-15 transpresentation.  Never 
before had the role of ICAM-1in CD8 T cells been addressed using these types of assays and 
readouts.  Whereas most lines of inquiry focus on the role of ICAM-1 in infections, its role in 
homeostatic processes outside of homing had not been considered.   
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Using VSV as an infectious agent I found that there were no IL-15-related deficiencies in 
ICAM-1-deficient mice.  The kinetics of the expansion and contraction of antigen-specific CD8 
T cells were the same in both Wt and ICAM-1-/- mice (Figure 12A).  The level of VSV-specific 
memory CD8 T cells in the spleen (Figure 12B) and BM (not shown) was actually slightly 
higher in ICAM-1-/-, as was the amount of BrdU incorporation among memory cells over a two 
week assay.  I also showed that cytokine production was not impaired in memory CD8 T cells 
generated in ICAM-1-/- mice.  These findings regarding immune responses in ICAM-1-/- mice 
disagree with the current literature in that previous studies have shown the generation of CD8 
T cell memory to be defective in the absence of ICAM-1.   
 
6.1.3   Summary of chapter 5 
Early findings that for memory CD8 T cells, IL-15 expression and transpresentation were 
required by BM-derived cells invited a relatively straightforward question – which cells derived 
from hematopoietic progenitors express IL-15?  Throughout my graduate studies I attempted 
to address this question but found no success.  Through the use of the transgenic mouse I’ve 
described in chapter 3, I indirectly showed that DCs must express IL-15.  However, it also 
became apparent that cells other than DCs transpresent IL-15 as well, which necessitated the 
revivification of my efforts to describe IL-15 expression within the hematopoietic compartment.  
Despite many attempts, I was forced to conclude that IL-15 expression at steady-state 
conditions is too low to detect, potentially due to a lack of sensitivity in my assays or by active 
down-regulation.  By qtPCR I demonstrated that IL-15 mRNA is rather widely expressed 
various BM-derived cells and that whereas DCs are important in IL-15 transpresentation, the 
level of transcript they contain is relatively low.  The serendipitous observation that IL-15 is 
apparently spontaneously expressed after overnight culture enabled the detection of IL-15 
expression on DCs among other BM-derived cells.  Additionally, in RAG-1-/- mice, I observed 
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that DCs as well as eosinophils and neutrophils express IL-15.  IL-15 expression by 
neutrophils and eosinophils is an unanticipated finding and had not been previously described 
or even suspected.  I was not able to assess the functional consequence of IL-15 expression 
by these cells due to the lack of models that selectively lack neutrophils or eosinophils.  
Nevertheless, these cells may be involved in providing IL-15 during the contraction of an 
immune response as transpresentation by DCs alone did not recoup a Wt phenotype.  
Sublethal irradiation also induced an increase in IL-15 expression on monocytes, DCs and 
eosinophils; however, the exact mechanism behind this has yet to be fully described.  Overall I 
determined that IL-15 is more widely expressed than previously thought and was able to build 
a comparative analysis of IL-15 expression in various environments. 
 
6.2  Future Directions 
6.2.1  IL-15 transpresentation and DCs 
As the CD8 T cell immune responses progresses, it becomes increasingly more dependent on 
IL-15 transpresentation by DCs.  While transpresented IL-15 isn’t important for the initial 
expansion phase, CD8 T cells need IL-15 during the contraction for their survival.  DCs 
provide some of the needed IL-15 but macrophages also apparently supply IL-15 at this time.  
In the memory phase, however, IL-15 transpresented limited to DCs is almost completely 
sufficient to drive memory CD8 T cell homeostatic proliferation.  The reason behind the 
progressive dependence on IL-15 provided by DCs is unknown.  Memory CD8 T cells are 
found to reside in B cell zones, marginal zones, T cell zones as well as the red pulp (95,96).  
Subsets of memory CD8 T cells also have specific microniches: Tcm reside in T cell zones 
and Tem reside in marginal zones and in the red pulp (96).  The consequence of memory CD8 
T cells residing in B cell zones is unknown, but the lack of memory CD8 T cells in T cell zones 
in favor of marginal zones is intriguing.  The spleen is home to two major types of antigen-
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presenting DCs which can be distinguished by the differential expression of CD8α.  CD8α+ 
DCs reside primarily in T cell zones of the spleen and CD8α- DCs are found in the marginal 
zones and red pulp (97).  While our study of DC-specific IL-15 transpresentation did not 
distinguish between these two subsets of DCs, it remains possible that the workload of IL-15 
transpresentation falls on one subset and not the other.  The localization of memory CD8 T 
cells in the red pulp and marginal zones and the localization of CD8α- DCs in these areas 
suggests that if indeed a differential workload exists, it likely falls on CD8α- DCs.  Previous 
studies did not determine if these two cells do colocalize in these areas but this would be a 
relatively straightforward relationship to establish if indeed it does exist.  A strategy that could 
be employed to determine if one DC subset is more important for transpresentation of IL-15 
could involve the use of our CD11c/IL-15Rα Tg mice.  The use of CD8-Cre mice (98) that have 
been crossed to IL-15Rα-loxp (72) mice would eliminate IL-15Rα expression on CD8 T cells 
but also on CD8α+ DCs.  These mice can be crossed to our CD11c/IL-15Rα Tg mice (58) to 
have CD8α+ DCs that are unable to transpresent IL-15, which can be compared to mice in 
which both DC subsets can transpresent IL-15.  If the hypothesis that CD8α- DCs are the main 
transpresenters of IL-15, the lack of ability to transpresent IL-15 by CD8α+ DCs should be of 
no consequence.  As it has already been determined that CD8 T cells do not require IL-15Rα 
expression (38,39), the absence of IL-15Rα on the triple-transgenic mice should not influence 
the outcome. To normalize for this complication, memory OT-I T cells on the IL-15Rα-/- 
background could be CFSE-labeled and adoptively transferred into both mice.   
 
6.2.2 Adhesion molecules in IL-15 transpresentation 
As I demonstrated in chapter 3, ICAM-1 does play a role in IL-15 transpresentation under 
homeostatic conditions: however, ICAM-1 expression is not strictly required to generate IL-15 
responses.  Because ICAM-1-/- mice are commercially available, we used these mice in our 
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studies first.  As mentioned previously, however, ICAM-1 pairs with LFA-1 on CD8 T cells, but 
LFA-1 can also pair with ICAM-2 and ICAM-3.  Both ICAM-2 and ICAM-3 are expressed on 
lymphocytes as well as ICAM-1 so it is possible that IL-15 transpresentation involves some 
combination of these molecules, or potentially all three.  The finding that memory CD8 T cells 
lacking CD11a largely failed to undergo homeostatic proliferation supports this hypothesis 
(Figure 11).  While ICAM-3-/- mice have not been generated, ICAM-2-/- and ICAM-1-/- ICAM-2-/- 
mice exist and could be utilized to study the role of ICAM-2, singly or in conjunction with ICAM-
1, in IL-15 transpresentation.   
 
The concept of IL-15 transpresentation resembling the synapse formed during antigen 
presentation invites similar studies to be performed involving the imaging of this interaction.  
However, as IL-15 transpresentation is still a poorly understand event, this undertaking is likely 
to be difficult.  One study that utilized conjugations between NK cells and poly I:C-activated 
DCs showed IL-15Rα clustering at the synapse; however, IL-15Rα was found to cluster on NK 
cells in this model and not on DCs as may be expected (99).  Another interesting aspect of this 
study revealed that blocking ICAM-1, -2, and -3 in addition to LFA-1 and LFA-3 to prevent 
synapse formation inhibited NK cell survival over a 9 day period (99).  This reduction in 
survival was related to IL-15Rα expression on NK cells (99), but nonetheless suggests that 
adhesion molecules are indeed important in IL-15 responses.  Adapting this model of 
conjugate-formation to study CD8 T cell and DC interactions would be very useful in further 
establishing a relationship between adhesion molecules – whether it’s one or all ICAM 
molecules – and IL-15 transpresentation. 
 
The affinity of LFA-1 binding can be regulated by altering the conformation of the molecule, 
such that when closed, LFA-1 binds with low affinity.  Conversely, LFA-1 binds with high 
affinity when open.  As discussed in chapter 1.5, TCR signals as well as chemokine signals 
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can regulate this affinity.  Additionally, a molecule associated with memory CD8 T cells, Ly6C, 
has also been shown to regulate the function of LFA-1(100,101).  The ligand for Ly6C has not 
been determined, however it is expressed on B cells (102).  As memory CD8 T cells primarily 
reside in B cell zones of the spleen (95,96), it is possible that they are receiving a signal that 
could modulate the affinity of LFA-1 via Ly6C stimulation.  In so doing, memory CD8 T cells 
would be more likely to form stronger contacts with DCs, which could be essential for IL-15 
transpresentation.  While this remains pure speculation at this point, investigating the 
relationship of Ly6C and LFA-1 as modulators of a memory CD8 T cell’s ability to receive 
transpresented IL-15 could be very exciting as it would demonstrate an unanticipated 
orchestration of events requiring crosstalk between multiple cell types.   
 
6.2.3  Regulation of IL-15 expression 
Our observation that IL-15 is increased in RAG-1-/- mice necessitates a thorough investigation 
to determine the cause for the altered expression.  As discussed before, the reason behind the 
increase in IL-15 could be due to the absence of either CD8 T cells or CD4 T cells.  We 
attempted some antibody depletion experiments in Wt mice to determine if the absence of 
either – or both – T cell subset gave us the same result.  These experiments yielded 
inconsistent results but done with more care or slightly different methodology may be effective.  
So far as we’ve been able to determine, the IL-15 in RAG-1-/- is constitutively elevated.  The 
time required after T cell depletion for any potential increase in IL-15 is therefore difficult to 
assess.  We also administered a blocking antibody against TGF-β as this is one way in which 
Tregs are known to act but these experiments did not yield any increase in IL-15; however, as 
before, timing may be an issue as well.  The finding that IL-15 is increased in ICAM-1-/- mice 
may suggest that ICAM-1 is involved in IL-15 regulation via cell-cell interactions, although 
again whether this is related to the ability of CD4 or CD8 T cells – or another cell altogether – 
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remains to be determined.  It is difficult to properly assess the influence Tregs have on IL-15 
expression directly because any mouse where Tregs are lacking suffers from severe 
inflammation.  To more specifically address the role TGF-β has on the expression of IL-15 in 
DCs or macrophages/granulocytes, TGF-βRII loxp mice (103) could be crossed to CD11c Cre 
(104) and LysM Cre (93) mice to render DCs and macrophages/granulocytes insensitive to 
TGF-β signals.  If expression of IL-15 is detected in these mice it would strongly suggest that 
TGF-β production is actively suppressing IL-15 expression in normal mice, likely through the 
function of Tregs.   
 
We used flow cytometry to measure IL-15 expression; however, this could also be approached 
by the use of microscopy and immunofluorescence.  We focused on cell surface IL-15 as this 
is where IL-15 is bioactive, but it would be very interesting to determine if IL-15 is maintained 
in intracellular storage.  We show that IL-15 is not detectable on the cell surface under 
homeostatic conditions, however we know that it is active.  It is possible that, given the right 
conditions and right signals, DCs could shuttle IL-15 to the cell surface to deliver this signal.  
Alternatively, DCs may constitutively display IL-15 on its surface and the interaction with a 
CD8 or CD4 T cell could instruct the DC to internalize the IL-15.  The detection of IL-15 
intracellularly could support either scenario – DCs hold the IL-15 in waiting or DCs internalize 
IL-15.  This could be addressed by culturing DCs from RAG-1-/- mice, which we know to 
express IL-15, with CD4 (CD25+ or -) or CD8 T cells and assaying for the presence or 
absence of cell surface IL-15.  As clathrin-mediated endocytosis is a commonly used pathway 
of membrane protein internalization, inhibitors that block this pathway, such as monensin or 
dynasore, could determine if surface IL-15 is endocytosed via this mechanism. 
 
6.3   General Discussion 
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The importance of IL-15 and CD8 T cell memory may be difficult to appreciate.   Why, after all, 
is immunological memory important when we can survive the infection in the first place?  In 
order to generate memory, one has to have undergone an immune response, so if that doesn’t 
kill us, why bother with CD8 T cell memory?  Most models that are used to study CD8 T cell 
memory involve acute viral or bacterial infections – VSV, LCMV and Listeria monocytogenes 
are three commonly used examples of such pathogens.  When infected, mice generate 
immune responses that are fully sufficient to combat these pathogens and either by virtue of 
the inherent immunogenicity of the pathogen or by the use of recombinant proteins carried by 
the pathogen, antigen-specific memory CD8 T cells are conveniently generated.  Such banal 
“lather, rinse, repeat” approaches – while undeniably convenient and necessary to our 
understanding – do not engender our full appreciation for the power of immune memory.  What 
if we encounter a pathogen that kills us before the adaptive immune system can mount a 
response?  Or, despite the induction of an adaptive immune response, we still succumb?  In 
these cases, we have no protection.  Through the use of vaccinations, however, we can 
generate immune responses to various pathogens that would otherwise be lethal and in so 
doing give ourselves a measure of protection.  By successfully eliciting a CD8 T cell response 
after vaccination, a pool of memory CD8 T cells will arise that will enable swifter control of an 
otherwise lethal pathogen.  This memory response could function either to eliminate infected 
cells rapidly enough to halt the spread of pathogen, or could delay the progress of the infection 
so that other components of the immune system can be engaged.  To illustrate this point, 
infection of mice all the way up the evolutionary ladder to humans with certain strains of the 
Ebola virus results in a rate of lethality rate as high as 90% (105), despite the ability of mice to 
generate an adaptive immune response (106).  However, protection from a lethal infection in 
naïve mice can be achieved by adoptively transferring CD8 T cells from immunized mice prior 
to challenge (107).  This example highlights the power and necessity of CD8 T cell memory.  
Of course, our knowledge of the power and utility of vaccination is only an application of a 
feature of the immune system that evolved long before humans began manipulating it for their 
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gain.  It is likely that the importance of CD8 T cell memory – in evolutionary terms – mainly 
functioned to lessen the severity of previously encountered pathogens and in so doing 
garnered better “fitness.”  However, our understanding of how we can apply this knowledge 
with today’s technology is where the real power of CD8 T cell memory can be appreciated.   
 
The findings presented herein have addressed several outstanding questions within the field of 
CD8 T cell memory.  I have established a new relationship between DCs and CD8 T cells, that 
of IL-15 transpresentation.  Cytokine presentation – in contrast to antigen presentation – 
requires a reevaluation of the known interactions between CD8 T cells and DCs, and 
macrophages as well.  Antigen presentation has a rather well defined context: typically, DCs 
will carry antigen to secondary lymphoid organs where the antigen will be presented to T cells.  
Cytokine presentation, on the other hand, happens in two distinct phases, both of which are 
poorly understood.  CD8 T cells receive IL-15 both during the contraction phase and memory 
phase from DCs and macrophages.  Now that this is established, we can begin looking at 
interactions between these cells as well as where they are located in tissues.  The micro 
niches wherein memory CD8 T cells have been demonstrated to reside gives us an indication 
as to with which cell – DC or macrophage – they are likely to interact.  This of course can be 
determined directly by immunofluorescence staining but it can be extended to determine if IL-
15 signals are being transmitted at the time of cellular colocalization and interaction.  The 
presence of IL-15Rα on one side of the synapse and a signaling molecule such as 
phosphorylated STAT5 on the other would indicate the transmission of IL-15 signals and 
would be another testament to the ability of DCs or macrophages to transpresent IL-15.  
Various hematopoietic cells share the expression of a wide variety of cell surface markers 
which can make their identification by flow cytometry very difficult.  An approach such as this, 
using microscopy and immunofluorescence, may serve to disambiguate the identity of cytokine 
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presenting cells as tissue localization as well as context may better serve to identify 
hematopoietic cells (108-111).   
 
The relationship between IL-15 expression and irradiation is a particularly interesting finding as 
it can have various clinical implications.  As mentioned before, IL-15 has been demonstrated 
to be important for the control of tumor growth.  Perhaps instead of using irradiation as a 
means to induce DNA damage and therefore cell death, it can be utilized more as an immune 
modulator.  If indeed the irradiation is working via the induction of IFN-α expression to up-
regulate IL-15, this may be used as a more controlled and targeted way to utilize IFN-α as well 
as IL-15.  A limited but focused increase in IFN-α expression would cut down on the side 
effects associated with this treatment and perhaps have better efficacy.  Radiation delivered to 
the tumor itself may result in DCs within the tumor microenvironment that – by virtue of their 
increased IL-15 expression – can induce CD8 T cell responses to self-antigens that would 
otherwise be left alone.  Our in vitro culture model showed that DCs need to express MHC 
class I in addition to ICAM-1 and IL-15Rα to elicit proliferation of memory-phenotype CD8 T 
cells.  This may be a model of how such a scenario could work, albeit in our model IL-15 up-
regulation was achieved by poly I:C stimulation.     
 
Overall I’ve demonstrated a new relationship between DCs and CD8 T cells in the context of 
the cytokine IL-15.  Under steady state conditions, IL-15 transpresentation is enhanced by the 
expression of ICAM-1 but where IL-15 expression is increased, ICAM-1 is not necessary for 
IL-15 transpresenation (Figure 22).   
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Figure 22.  The role of ICAM-1 in IL-15 transpresentation.   
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Figure 22.  The role of ICAM-1 in IL-15 transpresentation.  Model depicting the relationship 
between dendritic cells and CD8 T cells and the role of ICAM-1 in IL-15 transpresenation.  
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Chapter 7 – Materials and Methods 
 
7.1  Mice 
 
C57Bl/6 (both CD45.2+ and Thy1.1+) and ICAM-1-/- mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME).  CD45.1+ C57Bl/6 mice were purchased from Charles River 
(Wilmington, MA) through the National Cancer Institute (NCI) program.  IL-15-/- mice were 
purchased from Taconic.  CD11a-/- mice were generously provided by Qing Ma (UT MD 
Anderson Cancer Center, Houston, TX).  CD45.1+ OT-I transgenic RAG-1-/- and IL-15Rα-/- 
mice were bred in-house.  RAG-1-/- x ICAM-1-/- and RAG-1-/- x IL-15Rα-/- strains were 
developed in house by crossing ICAM-1-/-  and IL-15Rα-/- mice to the RAG-1-/- background.  
Bone marrow chimeras were generated as previously described(41).  For irradiation 
experiments, mice were irradiated with 750 cGy.  All mice were bred and maintained under 
specific-pathogen free conditions at MD Anderson Cancer Center (Houston, TX).  All 
experiments were performed with the approval of the Institutional Animal Care and Usage 
Committee of MD Anderson Cancer Center. 
 
7.2  Generation of CD11c/IL-15Rα Tg mice 
 
“The full length murine IL-15Rα cDNA was cloned by PCR from cDNA generated from 
C57Bl/6 spleen RNA using TA Topo cloning kit (Invitrogen). The IL-15Rα cDNA was 
then subcloned downstream of the CD11c promoter by ligating into the pCD11c-pDOI-
5 vector(56) (graciously provided by Thomas Brocker) at EcoRI site. The final 7.4 kb 
CD11c-IL-15Rα fragment was removed from the vector backbone by XhoI and NotI 
digestion and used for microinjection into C57Bl/6 pronuclei for generation of 
transgenic mice. Microinjection was performed by the Genetically-Engineered Mouse 
111 
 
Facility at the UT MD Anderson Cancer Center.  Tg-positive mice were identified by 
PCR of tail DNA and bred to IL-15Rα-/- background.” (58) This research was 
originally published in Blood. Stonier, S.W., Ma, L.J., Castillo, E.F., and Schluns, 
K.S. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. 
Blood. 2008; 112:4546-4554. © the American Society of Hematology. 
 
7.3   Endogenous immune responses 
 
For studies of a viral immune response, Wt, IL-15Rα-/-, and ICAM-1-/- mice were infected 
intravenously with 1x105 pfu VSV-Indiana.  Peripheral blood was collected via retro-orbital 
bleeds at the indicated times.  Red blood cells were lysed with 155 mM NH4Cl buffered with 
130 mM Tris.  Antigen-specific CD8 T cells were detected using an H-2Kb tetramer (National 
Institutes of Health [NIH] tetramer facility) loaded with the VSV nucleoprotein epitope 
(RGYVYQGL) as previously described (41).   
 
7.4   In vivo homeostatic proliferation assays  
 
Proliferation of endogenous memory CD8 T cells was assessed by BrdU incorporation.  VSV-
infected mice were given BrdU in their drinking water (0.8 mg/ml) for 5-6 weeks.  Cells were 
stained for surface markers as usual followed by staining using BrdU Flow Kit (BD 
Biosciences) according to manufacturer’s instructions.  For transfer studies of homeostatic 
proliferation, congenically-marked CD8 T cells were enriched from spleens of unmanipulated 
or immunized mice, where indicated.  To establish antigen-specific CD8 T cell memory, 
C57BL/6 mice were infected i.v. with 1 x 10
5
 pfu VSV and in some cases boosted at least 30 
days post infection with VSV-New Jersey.  Alternatively, memory OT-I T cells was generated 
as described(112).  Spleens were harvested at least 30 days following most recent infection 
and CD8 T cells were enriched using a CD8 T cell negative enrichment kit (Invitrogen, 
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Carlsbad, CA).  Enriched CD8 T cells were labeled with 2 mM CFSE, and injected i.v. into 
various recipients (between 5 and 10x10
6 cells/mouse).  The enrichments typically yielded a 
purity of 80-85% with minor cellular contamination that included NK cells and DCs. 
 
7.5   Acute proliferation assays in vivo 
 
Where indicated, CD8 T cell memory was generated as previously described.  CD8 T cell 
enrichments and CFSE labeling were performed as before.  For poly I:C-induced bystander 
proliferation, CD8 T cells were transferred into Wt and ICAM-1-/- mice.  One day post-transfer, 
recipient mice were given 150 µg poly I:C (InvivoGen, San Diego, CA) IP.  Five days later, 
proliferation was assessed.  For lymphopenia-induced proliferation, prior to transfer RAG-1-/- , 
RAG-1-/- x ICAM-1-/- and RAG-1-/- x IL-15Rα-/- mice were injected with 0.5 mg blocking Ab 
against IL-7Rα.  Additionally, IL-7Rα was blocked on enriched CD8 T cells prior to transfer.  
Mice were given an additional dose of anti- IL-7Rα during the five day incubation, after which 
tissues were harvested and proliferation analyzed. 
 
  
7.6  Cocultures of CD8 T cells and BMDCs 
 
BMDCs were generated with GM-CSF as previously described(113). Prior to culturing with 
CD8 T cells, BMDCs were activated with 100 µg/ml poly I:C for 12-16 hours. For BrdU 
incorporation studies, enriched CD8 T cells were cocultured with poly I:C-stimulated BMDCs 
in complete media (CM [RPMI with 10%FCS, 10mM HEPES, 50µM 2-ME]) supplemented with 
1 mM BrdU for three days.  BrdU incorporation was detected using the BrdU Flow Kit (BD 
Biosciences) according to manufacturer’s instructions. For phosphorylated STAT5 (pSTAT5) 
studies, enriched splenic CD8 T cells (CD45.1+) were serum starved for 5h prior to coculturing 
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with DCs (3:1 DC:CD8 ratio).  Cells were cocultured for 1h then fixed immediately in 1x 
Lyse/Fix Buffer (BD Biosciences), then frozen overnight in PBS and permeabilized with Perm 
Buffer III (BD Biosciences).  pSTAT5 was detected using an anti-STAT5 (pY694) antibody (BD 
Biosciences) according to the manufacturer’s instructions.   
 
7.7   Flow cytometry analysis 
 
IL-15Rα and IL-15 were detected with goat anti–IL-15Rα-biotin (R&D Systems, Minneapolis, 
MN) and rabbit anti–IL-15 biotin (Peprotech, Rocky Hill, NJ), respectively, followed by 
streptavidin-APC (Jackson ImmunoResearch Laboratories, West Grove, PA). Background 
staining was determined by staining analogous populations from either IL-15Rα-/- or IL-15-/- 
mice or with a biotinylated Ig control (Jackson ImmunoResearch Laboratories). Prior to 
staining for IL-15 and IL-15Rα, cells were preincubated with Fc block (BD Biosciences, San 
Jose, CA). The following monoclonal, fluorescently-labeled antibodies (mAbs) were purchased 
from either BD Biosciences, eBioscience (San Diego, CA), or BioLegend (San Diego, CA): 
CD44, CD62L, CD8α, CD19, CD3, DX5, CD4, CD11b, CD11c, CD127, Thy1.1, KLRG-1, 
CD27, CCR3, F4/80, Gr-1, FcεRI, B220, Ly6C, TCRβ, CD45.1 and MHC class II (I-Ab). LPS 
stimulation for IL-15 expression was performed with bulk splenocytes in CM, in the presence 
or absence of 1 µg/mL LPS (Sigma-Aldrich, St Louis,MO) for 24 hours.  IFN-α stimulation was 
performed as with LPS but with 300 U/ml IFN-α (source). 
 
Flow cytometry data were acquired using the Fortessa, LSRII, and FACSCalibur flow 
cytometers (all BD Biosciences, San Jose, CA) and analyzed with FlowJo software (Treestar, 
Ashland, OR). Lymphocyte percentages and total cell numbers were calculated and evaluated 
using the Student t test. Values of p less than .05 were considered statistically significant. 
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7.8   qtPCR 
 
RNA was isolated from sorted cell populations using Trizol (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s protocol.  cDNA was synthesized using the Superscript II 
reverse transcriptase (Invitrogen, Carlsbad, CA).  iQ SYBR supermix (Bio-rad, Hercules, CA) 
was used to conduct quantitative PCR assays which were all done in triplicate.  Expression of 
IL-15 was determined by the following formula, applied to each reaction:  
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